Search Legislation

Advanced Search

Commission Directive 2009/2/ECShow full title

Commission Directive 2009/2/EC of 15 January 2009 amending, for the purpose of its adaptation to technical progress, for the 31st time, Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (Text with EEA relevance)

Help about what version

What Version

Help about advanced features

Advanced Features

Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

This item of legislation originated from the EU

Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).

Status:

EU Directives are published on this site to aid cross referencing from UK legislation. Since IP completion day (31 December 2020 11.00 p.m.) no amendments have been applied to this version.

Commission Directive 2009/2/EC

of 15 January 2009

amending, for the purpose of its adaptation to technical progress, for the 31st time, Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Directive 67/548/EEC of 27 June 1967 on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances(1), and in particular Article 28 thereof,

Whereas:

(1) Article 4(3) of Directive 67/548/EEC sets out the criteria and the procedure to be followed to harmonise the classification and labelling of substances. Paragraphs 4.1.3, 4.1.4 and 4.1.5 of Annex VI to Directive 67/548/EEC oblige industry to provide information to Member States and Member States to make proposals for harmonised classification and labelling as a matter of urgency, when information becomes available justifying that a substance fulfils the criteria as a mutagenic, carcinogenic or reproductive toxic chemical.

(2) Annex I to Directive 67/548/EEC contains a list of dangerous substances, together with particulars of the classification and labelling of each substance. That list needs to be updated to include further notified new substances and further existing substances, as well as to adapt certain entries to technical progress. In addition, it is necessary, in that Annex, to delete entries for certain substances.

(3) Annex I to Directive 67/548/EEC already contains numerous group entries in particular for metal compounds evaluated using a grouping and read across approach based on analogy between substances.

(4) Annex I to Directive 67/548/EEC also contains certain groups where members of the group are identified and where the classification was derived by applying grouping and read across approaches, notably the petroleum streams and gasses.

(5) Annex VI to Directive 67/548/EEC states that the data required for classification and labelling may be obtained from a number of different sources, including the results of validated structure-activity relationships and expert judgement.

(6) The classifications of the nickel compounds listed in this Directive are based on the effects originating from the Ni(2+) ion and on the available data for nickel compounds. The classifications were derived by grouping nickel compounds into categories on the basis of water solubility (e.g. groups insoluble, slightly soluble and soluble nickel compounds respectively). Water solubility was used as an initial criterion to define these categories, based on the argument that nickel substances having similar water solubility will indicate similar bioavailability of the Ni(2+) ion and similar systemic toxicity. This justifies a read across within groups from the substances for which the available adequate test data demonstrate a specific systemic effect to those lacking such test data. For some effects, read across between groups is justified, as similar effects have been observed across the range of water solubility. For example, epidemiological studies show that both soluble and insoluble nickel compounds (at opposite ends of the range of solubility) have local carcinogenic effects in the respiratory tract. There is, therefore, good reason to conclude that slightly soluble compounds (at the middle of this range) have similar carcinogenic properties.

(7) As part of an evaluation of all the available information for the nickel compounds, water solubility can be used as an approximation of systemic bioavailability of the Ni(2+) ion for many effects and substances.

(8) The classification and labelling of the substances listed in this Directive should be reviewed if new scientific knowledge becomes available. In this context, noting in particular that the nickel industry has recently submitted preliminary, partial and not peer-reviewed information, special attention should be paid to the outcome of future discussions within the World Health Organisation's International Agency for Research on Cancer on the carcinogenicity of nickel substances, or to any relevant new scientific findings or interpretations of the data used to establish the classifications for the nickel compounds included in this Directive.

(9) The measures provided for in this Directive are in accordance with the opinion of the Committee on the Adaptation to Technical Progress of the Directives for the Elimination of Technical Barriers to Trade with Dangerous Substances and Preparations,

HAS ADOPTED THIS DIRECTIVE:

Article 1U.K.

Directive 67/548/EEC is amended as follows. Annex I is amended as follows:

(a)

the entries corresponding to the entries set out in Annex 1A to this Directive are replaced by the entries set out in that Annex;

(b)

the entries set out in Annex 1B to this Directive are inserted in accordance with the order of the entries set out in Annex I to Directive 67/548/EEC;

(c)

the entries set out in Annex 1C to this Directive are deleted.

Article 2U.K.

Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 1 June 2009 at the latest. They shall forthwith communicate to the Commission the text of those provisions and a correlation table between those provisions and this Directive.

When Member States adopt those provisions, they shall contain a reference to this Directive or be accompanied by such a reference on the occasion of their official publication. Member States shall determine how such reference is to be made.

Member States shall communicate to the Commission the text of the main provisions of national law which they adopt in the field covered by this Directive.

Article 3U.K.

This Directive shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Article 4U.K.

This Directive is addressed to the Member States.

Done at Brussels, 15 January 2009.

For the Commission

Stavros Dimas

Member of the Commission

ANNEX 1AU.K.

Index NoChemical nameNotes related to substancesEC NoCAS NoClassificationLabellingConcentration LimitsNotes related to preparations
001-002-00-4aluminium lithium hydride240-877-916853-85-3

F; R15

C; R35

F; C

R: 15-35

S: (1/2-)7/8-26-36/37/39-43-45

005-006-00-7dibutyltin hydrogen borateE401-040-575113-37-0

Muta. Cat. 3; R68

Repr. Cat. 2; R60-61

T; R48/25

Xn; R21/22

Xi; R41

R43

N; R50-53

T; N

R: 60-61-21/22-41-43-48/25-68-50/53

S: 53-45-60-61

006-007-00-5salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this AnnexA——

T+; R26/27/28

R32

N; R50-53

T+; N

R: 26/27/28-32-50/53

S: (1/2-)7-28-29-45-60-61

006-015-00-9

diuron (ISO);

3-(3,4-dichlorophenyl)-1,1-dimethylurea

206-354-4330-54-1

Carc. Cat. 3; R40

Xn; R22-48/22

N; R50-53

Xn; N

R: 22-40-48/22-50/53

S: (2-)13-36/37-46-60-61

C ≥ 25 %: Xn, N; R22-40-48/22-50/53

10 % ≤ C < 25 %: Xn, N; R40-48/22-50/53

2,5 % ≤ C < 10 %: Xn, N; R40-50/53

1 % ≤ C < 2,5 %: Xn, N; R40-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

006-076-00-1

mancozeb (ISO);

manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt

—8018-01-7

Repr. Cat. 3; R63

R43

N; R50

Xn; N

R: 43-63-50

S: (2-)36/37-46-61

C ≥ 5 %: Xn, N; R43-63-50

2,5 ≤ C < 5 %: Xi, N; R43-50

1 % ≤ C < 2,5 %: Xi; R43

006-077-00-7

maneb (ISO);

manganese ethylenebis(dithiocarbamate) (polymeric)

235-654-812427-38-2

Repr. Cat. 3; R63

Xn; R20

Xi; R36

R43

N; R50-53

Xn; N

R: 20-36-43-63-50/53

S: (2-)36/37-46-60-61

C ≥ 25 %: Xn, N; R20-36-43-63-50/53

20 % ≤ C < 25 %: Xn, N; R36-43-63-50/53

5 % ≤ C < 20 %: Xn, N; R43-63-50/53

2,5 % ≤ C < 5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

006-084-00-5

carbosulfan (ISO);

2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate

259-565-955285-14-8

T+; R26

T; R25

R43

N; R50-53

T+; N

R: 25-26-43-50/53

S: (1/2-)28-36/37-38-45-63-60-61

006-088-00-7

benfuracarb (ISO);

ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl-β-alaninate

—82560-54-1

Repr. Cat. 3; R62

T; R23

Xn; R22

N; R50-53

T; N

R: 22-23-62-50/53

S: (1/2-)36/37-45-60-61

007-002-00-0

nitrogen dioxide; [1]

dinitrogen tetraoxide [2]

233-272-6 [1]

234-126-4 [2]

10102-44-0 [1]

10544-72-6 [2]

O; R8

T+; R26

C; R34

O; T+

R: 8-26-34

S: (1/2-)9-26-28-36/37/39-45

C ≥ 10 %: T+; R26-34

5 % ≤ C < 10 %: T; R23-34

1 % ≤ C < 5 %: T; R23-36/37/38

0,5 % ≤ C < 1 %: Xn; R20-36/37/38

0,1 % ≤ C < 0,5 %: Xn; R20

5
015-041-00-X

malathion (ISO);

1,2-bis(ethoxycarbonyl)ethyl O,O-dimethyl phosphorodithioate;

[containing ≤ 0,03 % isomalathion]

204-497-7121-75-5

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)24-37-46-60-61

C ≥ 25 %: Xn, N; R22-43-50/53

1 % ≤ C < 25 %: Xi, N; R43-50/53

0,025 % ≤ C < 1 %: N; R50/53

0,0025 % ≤ C < 0,025 %: N; R51/53

0,00025 % ≤ C < 0,0025 %: R52/53

015-100-00-X

phoxim (ISO);

α-(diethoxyphosphinothioylimino) phenylacetonitrile

238-887-314816-18-3

Repr. Cat. 3; R62

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-62-50/53

S: (2-)36/37-46-60-61

C ≥ 25 %: Xn, N; R22-43-62-50/53

5 % ≤ C < 25 %: Xn, N; R43-62-50/53

1 % ≤ C < 5 %: Xi, N; R43-50/53

0,025 % ≤ C < 1 %: N; R50/53

0,0025 % ≤ C < 0,025 %: N; R51/53

0,00025 % ≤ C < 0,0025 %: R52/53

015-102-00-0tris(2-chloroethyl)phosphateE204-118-5115-96-8

Carc. Cat. 3; R40

Repr. Cat. 2; R60

Xn; R22

N; R51-53

T; N

R: 60-22-40-51/53

S: 53-45-61

015-155-00-X

glufosinate ammonium (ISO);

ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate

E278-636-577182-82-2

Repr. Cat. 2; R60

Repr. Cat. 3; R63

Xn; R20/21/22-48/20/22

T

R: 60-20/21/22-48/20/22-63

S: 53-45

016-009-00-8

disodium sulfide;

sodium sulfide

215-211-51313-82-2

T; R24

Xn; R22

C; R34

R31

N; R50

T; C; N

R: 22-24-31-34-50

S: (1/2-)26-36/37/39-45-61

017-009-00-0

ammonium perchlorate;

[containing ≥ 80 % of 0-30 μm particles]

T232-235-17790-98-9

E; R3

O; R9

E

R: 3-9

S: (2-)14-16-36/37

024-004-00-7sodium dichromateE234-190-310588-01-9

O; R8

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Repr. Cat. 2; R60-61

T+; R26

T; R25-48/23

Xn; R21

C; R34

R42/43

N; R50-53

O; T+; N

R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53

S: 53-45-60-61

C ≥ 25 %: T+, N; R45-46-60-61-21-25-26-34-42/43-48/23-50/53

10 % ≤ C < 25 %: T+, N; R45-46-60-61-22-26-34-42/43-48/23-51/53

7 % ≤ C < 10 %: T+, N; R45-46-60-61-22-26-36/37/38-42/43-48/20-51/53

5 % ≤ C < 7 %: T, N; R45-46-60-61-22-23-36/37/38-42/43-48/20-51/53

3 % ≤ C < 5 %: T, N; R45-46-60-61-22-23-42/43-48/20-51/53

2,5 % ≤ C < 3 %: T, N; R45-46-60-61-23-42/43-48/20-51/53

1 % ≤ C < 2,5 %: T; R45-46-60-61-23-42/43-48/20-52/53

0,5 % ≤ C < 1 %: T; R45-46-60-61-20-42/43-52/53

0,25 % ≤ C < 0,5 %: T; R45-46-20-42/43-52/53

0,2 % ≤ C < 0,25 %: T; R45-46-20-42/43

0,1 % ≤ C < 0,2 %: T; R45-46-20

3
027-002-00-4cobalt oxide215-154-61307-96-6

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)24-37-60-61

C ≥ 25 %: Xn, N; R22-43-50/53

2,5 % ≤ C < 25 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

027-003-00-Xcobalt sulfide215-273-31317-42-6

R43

N; R50-53

Xi; N

R: 43-50/53

S: (2-)24-37-60-61

C ≥ 2,5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

028-003-00-2

nickel monoxide; [1]

nickel oxide; [2]

bunsenite [3]

E

215-215-7 [1]

234-323-5 [2]

- [3]

1313-99-1 [1]

11099-02-8 [2]

34492-97-2 [3]

Carc. Cat. 1; R49

T; R48/23

R43

R53

T

R: 49-43-48/23-53

S: 53-45-61

028-004-00-8nickel dioxideE234-823-312035-36-8

Carc. Cat. 1; R49

T; R48/23

R43

R53

T

R: 49-43-48/23-53

S: 53-45-61

028-005-00-3dinickel trioxideE215-217-81314-06-3

Carc. Cat. 1; R49

T; R48/23

R43

R53

T

R: 49-43-48/23-53

S: 53-45-61

028-006-00-9

nickel (II) sulfide; [1]

nickel sulfide; [2]

millerite [3]

E

240-841-2 [1]

234-349-7 [2]

- [3]

16812-54-7 [1]

11113-75-0 [2]

1314-04-1 [3]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-68-50/53

S: 53-45-60-61

028-007-00-4

trinickel disulfide;

nickel subsulfide; [1]

heazlewoodite [2]

E

234-829-6 [1]

- [2]

12035-72-2 [1]

12035-71-1 [2]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-68-50/53

S: 53-45-60-61

028-008-00-X

nickel dihydroxide; [1]

nickel hydroxide [2]

E

235-008-5 [1]

234-348-1 [2]

12054-48-7 [1]

11113-74-9 [2]

Carc. Cat. 1; R49

Repr. Cat. 2; R61

Muta. Cat. 3; R68

T; R48/23

Xn; R20/22

Xi; R38

R42/43

N; R50-53

T; N

R: 49-61-20/22-38-42/43-48/23-68-50/53

S: 53-45-60-61

029-013-00-Xtrisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II)407-580-8130201-51-3Xi; R41

Xi

R: 41

S: (2-)26-39

033-005-00-1arsenic acid and its salts with the exception of those specified elsewhere in this AnnexAE——

Carc. Cat. 1; R45

T; R23/25

N; R50-53

T; N

R: 45-23/25-50/53

S: 53-45-60-61

034-002-00-8selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this AnnexA——

T; R23/25

R33

N; R50-53

T; N

R: 23/25-33-50/53

S: (1/2-)20/21-28-45-60-61

047-001-00-2silver nitrate231-853-97761-88-8

O; R8

C; R34

N; R50-53

O; C; N

R: 8-34-50/53

S: (1/2-)26-36/37/39-45-60-61

050-002-00-0

cyhexatin (ISO);

hydroxytricyclohexylstannane;

tri(cyclohexyl)tin hydroxide

236-049-113121-70-5

Xn; R20/21/22

N; R50-53

Xn; N

R: 20/21/22-50/53

S: (2-)13-60-61

C ≥ 25 %: Xn, N; R20/21/22-50/53

0,025 % ≤ C < 25 %: N; R50/53

0,0025 % ≤ C < 0,025 %: N; R51/53

0,00025 % ≤ C < 0,0025 %: R52/53

050-003-00-6

fentin acetate (ISO);

triphenyltin acetate

212-984-0900-95-8

Carc. Cat. 3; R40

Repr. Cat. 3; R63

T+; R26

T; R24/25-48/23

Xi; R37/38-41

N; R50-53

T+; N

R: 24/25-26-37/38-40-41-48/23-63-50/53

S: (1/2-)26-28-36/37/39-45-60-61

C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53

20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53

10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53

7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53

5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53

3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53

2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53

1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53

0,25 % ≤ C < 1 %: Xn, N; R20-51/53

0,1 % ≤ C < 0,25 %: Xn; R20-52/53

0,025 % ≤ C < 0,1 %: R52/53

050-004-00-1

fentin hydroxide (ISO);

triphenyltin hydroxide

200-990-676-87-9

Carc. Cat. 3; R40

Repr. Cat. 3; R63

T+; R26

T; R24/25-48/23

Xi; R37/38-41

N; R50-53

T+; N

R: 24/25-26-37/38-40-41-48/23-63-50/53

S: (1/2-)26-28-36/37/39-45-60-61

C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53

20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53

10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53

7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53

5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53

3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53

2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53

1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53

0,25 % ≤ C < 1 %: Xn, N; R20-51/53

0,1 % ≤ C < 0,25 %: Xn; R20-52/53

0,025 % ≤ C < 0,1 %: R52/53

050-008-00-3tributyltin compounds, with the exception of those specified elsewhere in this AnnexA——

T; R25-48/23/25

Xn; R21

Xi; R36/38

N; R50-53

T; N

R: 21-25-36/38-48/23/25-50/53

S: (1/2-)36/37/39-45-60-61

C ≥ 2,5 %: T, N; R21-25-36/38-48/23/25-50/53

1 % ≤ C < 2,5 %: T, N; R21-25-36/38-48/23/25-51/53

0,25 % ≤ C < 1 %: Xn, N; R22-48/20/22-51/53

0,025 % C < 0,25 %: R52/53

1
050-011-00-Xtriphenyltin compounds, with the exception of those specified elsewhere in this AnnexA——

T; R23/24/25

N; R50-53

T; N

R: 23/24/25-50/53

S: (1/2-)26-27-28-45-60-61

C ≥ 1 %: T, N; R23/24/25-50/53

0,25 % ≤ C < 1 %: Xn, N; R20/21/22-50/53

0,025 % ≤ C < 0,25 %: N; R51/53

0,0025 % ≤ C < 0,025 %: R52/53

1
050-018-00-8tin(II) methanesulphonate401-640-753408-94-9

C; R34

Xn; R22

R43

N; R51-53

C; N

R: 22-34-43-51/53

S: (1/2-)22-26-36/37/39-45-61

053-003-00-4iodoxybenzene—696-33-3E; R2

E

R: 2

S: (2-)35

053-004-00-Xcalcium iodoxybenzoateC——E; R2

E

R: 2

S: (2-)35

080-001-00-0mercuryE231-106-77439-97-6

Repr. Cat. 2; R61

T+; R26

T; R48/23

N; R50-53

T+; N

R: 61-26-48/23-50/53

S: 53-45-60-61

080-010-00-X

mercury dichloride;

mercuric chloride

231-299-87487-94-7

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T+; R28

T; R48/24/25

C; R34

N; R50-53

T+; N

R: 28-34-48/24/25-62-68-50/53

S: (1/2-)26-36/37/39-45-60-61

092-002-00-3uranium compounds with the exception of those specified elsewhere in this AnnexA——

T+; R26/28

R33

N; R51-53

T+; N

R: 26/28-33-51/53

S: (1/2-)20/21-45-61

601-065-00-3

A mixture of: (1′α,3′α,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane);

(1′α,3′β,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane)

416-930-9—

Xi; R38

N; R51-53

Xi; N

R: 38-51/53

S: (2-)36/37-61

602-007-00-X

bromoform;

tribromomethane

200-854-675-25-2

T; R23

Xn; R22

Xi; R36/38

N; R51-53

T; N

R: 22-23-36/38-51/53

S: (1/2-)28-45-63-61

602-030-00-5

1,3-dichloropropene; [1]

(Z)-1,3-dichloropropene [2]

C D

208-826-5 [1]

233-195-8 [2]

542-75-6 [1]

10061-01-5 [2]

R10

T; R24/25

Xn; R20-65

Xi; R36/37/38

R43

N; R50-53

T; N

R: 10-20-24/25-36/37/38-43-65-50/53

S: (1/2-)36/37-45-60-61

602-054-00-6

3-iodpropene;

allyl iodide

209-130-4556-56-9

F; R11

C; R34

F; C

R: 11-34

S: (1/2-)7-16-26-45

603-005-00-1

2-methylpropan-2-ol;

tert-butyl alcohol

200-889-775-65-0

F; R11

Xn; R20

Xi; R36/37

F; Xn

R: 11-20-36/37

S: (2-)9-16-46

603-018-00-2furfuryl alcohol202-626-198-00-0

Carc. Cat. 3; R40

T; R23

Xn; R21/22-48/20

Xi; R36/37

T

R: 21/22-23-36/37-40-48/20

S: (1/2-)36/37-45-63

603-023-00-X

ethylene oxide;

oxirane

E200-849-975-21-8

F+; R12

R6

Carc. Cat. 2; R45

Muta. Cat. 2; R46

T; R23

Xi; R36/37/38

F+; T

R: 45-46-6-12-23-36/37/38

S: 53-45

603-029-00-2bis(2-chloroethyl) ether203-870-1111-44-4

Carc. Cat. 3; R40

T+; R26/27/28

T+

R: 26/27/28-40

S: (1/2-)7/9-27-28-36/37-45

C ≥ 7 %: T+; R26/27/28-40

1 % ≤ C < 7 %: T; R23/24/25-40

0,1 % ≤ C < 1 %: Xn; R20/21/22

603-037-00-6

cellulose nitrate;

nitrocellulose

T——E; R3

E

R: 3

S: (2-)35

603-046-00-5

bis(chloromethyl) ether;

oxybis(chloromethane)

E208-832-8542-88-1

F; R11

Carc. Cat. 1; R45

T+; R26

T; R24

Xn; R22

F; T+

R: 45-11-22-24-26

S: 53-45

C ≥ 25 %: T+; R45-22-24-26

7 % ≤ C < 25 %: T+; R45-21-26

3 % ≤ C < 7 %: T; R45-21-23

1 % ≤ C < 3 %: T; R45-23

0,1 % ≤ C < 1 %: T; R45-20

0,001 % ≤ C < 0,1 %: T; R45

603-064-00-3

1-methoxy-2-propanol;

monopropylene glycol methyl ether

203-539-1107-98-2

R10

R67

R: 10-67

S: (2-)

603-066-00-4

1,2-epoxy-4-epoxyethylcyclohexane;

4-vinylcyclohexene diepoxide

203-437-7106-87-6

Carc. Cat. 3; R40

T; R23/24/25

T

R: 23/24/25-40

S: (1/2-)36/37-45-63

C ≥ 1 %: T; R23/24/25-40

0,1 % ≤ C < 1 %: Xn; R20/21/22

605-004-00-1

2,4,6-trimethyl-1,3,5-trioxane;

paraldehyde

204-639-8123-63-7R10

R: 10

S: (2-)29

605-005-00-7

2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;

metaldehyde

203-600-2108-62-3

F; R11

Xn; R22

F; Xn

R: 11-22

S: (2-)13-16-25-46

606-021-00-7

N-methyl-2-pyrrolidone;

1-methyl-2-pyrrolidone

212-828-1872-50-4

Repr. Cat. 2; R61

Xi; R36/37/38

T

R: 61-36/37/38

S: 53-45

C ≥ 10 %: T; R61-36/37/38

5 % ≤ C < 10 %: T; R61

607-007-00-3salts of oxalic acid with the exception of those specified elsewhere in this AnnexA——Xn; R21/22

Xn

R: 21/22

S: (2-)24/25

C ≥ 5 %: Xn; R21/22
607-012-00-0benzoyl chloride202-710-898-88-4

Xn; R20/21/22

C; R34

R43

C

R: 20/21/22-34-43

S: (1/2-)26-36/37/39-45

607-037-00-7

2-ethoxyethyl acetate;

ethylglycol acetate

E203-839-2111-15-9

R10

Repr. Cat. 2; R60-61

Xn; R20/21/22

T

R: 60-61-10-20/21/22

S: 53-45

607-051-00-3

MCPA (ISO);

4-chloro-o-tolyloxyacetic acid

202-360-694-74-6

Xn; R22

Xi; R38-41

N; R50-53

Xn; N

R: 22-38-41-50/53

S: (2-)26-37-39-60-61

607-052-00-9salts and esters of MCPAA——

Xn; R20/21/22

N; R50-53

Xn; N

R: 20/21/22-50/53

S: (2-)13-60-61

607-085-00-9benzyl benzoate204-402-9120-51-4

Xn; R22

N; R51-53

Xn; N

R: 22-51/53

S: (2-)25-46-61

607-095-00-3maleic acid203-742-5110-16-7

Xn; R22

Xi; R36/37/38

R43

Xn

R: 22-36/37/38-43

S: (2-)24-26-28-37-46

C ≥ 25 %: Xn; R22-36/37/38-43

20 % ≤ C <25 %: Xi; R36/37/38-43

0,1 % ≤ C < 20 %: Xi; R43

607-103-00-5succinic anhydride203-570-0108-30-5

Xn; R22

Xi; R36/37

Xn

R: 22-36/37

S: (2-)25-46

C ≥ 5 %: Xn; R22-36/37

1 % ≤ C < 5 %: Xi; R36/37

607-142-00-8

propyl chloroformate;

chloroformic acid propylester;

n-propyl chloroformate

203-687-7109-61-5

F; R11

T; R23

C; R34

F; T

R: 11-23-34

S: (1/2-)16-26-36-45

607-195-00-72-methoxy-1-methylethyl acetate203-603-9108-65-6R10

R: 10

S: (2-)

607-216-00-Xglutamic acid, reaction products with N-(C12-14-alkyl)propylenediamine403-950-8—

T+; R26

Xn; R22

C; R34

N; R50

T+; N

R: 22-26-34-50

S: (1/2-)26-36/37/39-38-45-61

607-231-00-1

clopyralid (ISO);

3,6-dichloropyridine-2-carboxylic acid

216-935-41702-17-6Xi; R41

Xi

R: 41

S: (2-)26-39

607-245-00-8 tert-butyl acrylateD216-768-71663-39-4

F; R11

Xn; R20/21/22

Xi; R37/38

R43

N; R51-53

F; Xn; N

R: 11-20/21/22-37/38-43-51/53

S: (2-)16-25-37-61

C ≥ 25 %: Xn; R20/21/22-37/38-43-51/53

20 % ≤ C < 25 %: Xi; R37/38-43-52/53

2,5 % ≤ C < 20 %: Xi; R43-52/53

1 % ≤ C < 2,5 %: Xi; R43

607-397-00-5

A mixture of: Ca salicylates (branched C10-14 and C18-30 alkylated);

Ca phenates (branched C10-14 and C18-30 alkylated);

Ca sulfurised phenates (branched C10-14 and C18-30 alkylated)

415-930-6—

Repr. Cat. 3; R62

R43

Xn

R: 43-62

S: (2-)23-36/37

608-005-00-5 n-butyronitrile203-700-6109-74-0

F; R11

T; R23/24/25

F; T

R: 11-23/24/25

S: (1/2-)16-36/37-45-63

608-011-00-8

oxalonitrile;

cyanogen

207-306-5460-19-5

F+; R12

T; R23

N; R50-53

F+; T; N

R: 12-23-50/53

S: (1/2-)9-16-23-33-45-63-60-61

608-044-00-82-cyclohexylidene-2-phenylacetonitrile423-740-110461-98-0

Xn; R22

N; R51-53

Xn; N

R; 22-51/53

S: (2-)46-61

609-007-00-9

2,4-dinitrotoluene; [1]

dinitrotoluene [2]

E

204-450-0 [1]

246-836-1 [2]

121-14-2 [1]

25321-14-6 [2]

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T; R23/24/25

Xn; R48/22

N; R50-53

T; N

R: 45-23/24/25-48/22-62-68-50/53

S: 53-45-60-61

611-028-00-3 C,C′-azodi(formamide)204-650-8123-77-3

E; R2

R42

E; Xn

R: 2-42

S: (2-)22-24-37

611-035-00-1tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate403-660-1107246-80-0N; R51-53

N

R: 51/53

S: 61

612-044-00-3 N,N′-diacetylbenzidineE210-338-2613-35-4

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Xn; R20/21/22

T

R: 45-20/21/22-68

S: 53-45

612-050-00-6cyclohexylamine203-629-0108-91-8

R10

Repr. Cat. 3; R62

Xn; R21/22

C; R34

C

R: 10-21/22-34-62

S: (1/2-)26-36/37/39-45

C ≥ 25 %: C; R21/22-34-62

10 % ≤ C < 25 %: C; R34-62

5 % ≤ C < 10 %: Xn; R36/38-62

2 % ≤ C < 5 %: Xi; R36/38

612-076-00-8ethyldimethylamine209-940-8598-56-1

F; R11

Xn; R20/22

C; R34

F; C

R: 11-20/22-34

S: (1/2-)3-16-26-36-45

612-099-00-3

4-methyl-m-phenylenediamine;

2,4-toluenediamine

E202-453-195-80-7

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T; R25

Xn; R21-48/22

R43

N; R51-53

T; N

R: 45-21-25-43-48/22-62-68-51/53

S: 53-45-61

612-101-00-2

methenamine;

hexamethylenetetramine

202-905-8100-97-0

F; R11

R43

F; Xi

R: 11-43

S: (2-)24-37

612-151-00-5

methyl-phenylene diamine;

diaminotoluene;

[technical product - mixture of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)]

E——

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T; R25

Xn; R21-48/22

Xi; R36

R43

N; R51-53

T; N

R: 45-21-25-36-43-48/22-62-68-51/53

S: 53-45-61

612-237-00-2

hydroxylammonium hydrogensulfate;

hydroxylamine sulfate(1:1); [1]

hydroxylamine phosphate; [2]

hydroxylamine dihydrogenphosphate; [3]

hydroxylamine 4-methylbenzenesulfonate [4]

T

233-154-4 [1]

244-077-0 [2]

242-818-2 [3]

258-872-5 [4]

10046-00-1 [1]

20845-01-6 [2]

19098-16-9 [3]

53933-48-5 [4]

E; R2

Carc. Cat. 3; R40

Xn; R21/22-48/22

Xi; R36/38

R43

N; R50

E; Xn; N

R: 21/22-36/38-40-43-48/22-50

S: (2-)36/37-61

613-116-00-7

tolylfluanid (ISO);

dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;

[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

211-986-9731-27-1

T+; R26

T; R48/23

Xi; R36/37/38

R43

N; R50

T+; N

R: 26-36/37/38-43-48/23-50

S: (1/2-)28-36/37/39-45-63-61

C ≥ 20 %: T+, N; R26-36/37/38-43-48/23-50

10 % ≤ C < 20 %: T+, N; R26-43-48/23-50

7 % ≤ C < 10 %: T+, N; R26-43-48/20-50

2,5 % ≤ C < 7 %: T, N; R23-43-48/20-50

1 % ≤ C < 2,5 %: T; R23-43-48/20

0,1 % ≤ C < 1 %: Xn; R20

615-001-00-7methyl isocyanate210-866-3624-83-9

F; R11

Repr. Cat. 3; R63

T+; R26

T; R24/25

R42/43

Xi; R37/38-41

F; T+

R: 11-24/25-26-37/38-41-42/43-63

S: (1/2-)16-26-27/28-36/37/39-45-63

615-004-00-3salts of thiocyanic acid, with the exception of those specified elsewhere in this AnnexA——

Xn; R20/21/22

R32

R52-53

Xn

R: 20/21/22-32-52/53

S: (2-)13-36/37-46-61

615-028-00-4ethyl 2-(isocyanatosulfonyl)benzoate410-220-277375-79-2

R14

Xn; R22-48/22

Xi; R41

R42/43

Xn

R: 14-22-41-42/43-48/22

S: (2-)8-23-26-30-35-36/37/39

615-030-00-5alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this AnnexA——

Xn; R20/21/22

R32

R52-53

Xn

R: 20/21/22-32-52/53

S: (2-)13-36/37-46-61

615-031-00-0thallium thiocyanate222-571-73535-84-0

T+; R26/28

Xn; R21

R32

R33

N; R51-53

T+; N

R: 21-26/28-32-33-51/53

S: (1/2-)13-28-36/37-45-61

615-032-00-6metal salts of thiocyanic acid, with the exception of those specified elsewhere in this AnnexA——

Xn; R20/21/22

R32

N; R50-53

Xn; N

R: 20/21/22-32-50/53

S: (2-)13-36/37-46-60-61

616-124-00-9lithium bis(trifluoromethylsulfonyl)imide415-300-090076-65-6

T; R24/25

Xn; R48/22

C; R34

R52-53

T

R: 24/25-34-48/22-52/53

S: (1/2-)22-26-36/37/39-45-61

617-017-00-X

A mixture of: 2,2′-bis(tert-pentylperoxy)-p-diisopropylbenzene;

2,2′-bis(tert-pentylperoxy)-m-diisopropylbenzene

T412-140-332144-25-5

E; R2

O; R7

R53

E

R: 2-7-53

S: (2-)3/7-14-36/37/39-61

650-016-00-2

Mineral wool, with the exception of those specified elsewhere in this Annex;

[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight]

AQR——Carc. Cat. 3; R40

Xn

R: 40

S: (2-)36/37

650-017-00-8

Refractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex;

[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight]

AR——Carc. Cat. 2; R49

T

R: 49

S: 53-45

ANNEX 1BU.K.

Index NoChemical nameNotes related to substancesEC NoCAS NoClassificationLabellingConcentration LimitsNotes related to preparations
003-003-00-5

(2-methylpropyl)lithium;

isobutyllithium

440-620-2920-36-5

F; R15-17

R14

C; R35

R67

N; R50-53

F; C; N

R: 14/15-17-35-67-50/53

S: (1/2-)6-16-26-30-33-36/37/39-43-45-60-61

005-013-00-5diethylmethoxyborane425-380-97397-46-8

F; R17

Xn; R20/21/22-48/22

C; R34

R43

R53

F; C

R: 17-20/21/22-34-43-48/22-53

S: (1/2-)6-26-36/37/39-43-45-61

005-014-00-04-formylphenylboronic acid438-670-587199-17-5R43

Xi

R: 43

S: (2-)24-37

005-017-00-7

sodium perborate; [1]

perboric acid, sodium salt; [2]

perboric acid, sodium salt, monohydrate; [3]

sodium peroxometaborate; [4]

perboric acid (HBO(O2)), sodium salt, monohydrate; [5]

sodium peroxoborate;

[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

E

239-172-9 [1]

234-390-0 [2]

- [3]

231-556-4 [4]

- [5]

15120-21-5 [1]

11138-47-9 [2]

12040-72-1 [3]

7632-04-4 [4]

10332-33-9 [5]

O; R8

Repr. Cat. 2; R61

Repr. Cat. 3; R62

Xn; R22

Xi; R37-41

O; T

R: 61-8-22-37-41-62

S: 53-45

C ≥ 25 %: T; R61-22-37-41-62

22 % ≤ C < 25 %: T; R61-37-41-62

20 % ≤ C < 22 %: T; R61-36/37-62

14 % ≤ C < 20 %: T; R61-36-62

9 % ≤ C < 14 %: T; R61-62

6,5 % ≤ C < 9 %: T; R61

005-017-01-4

sodium perborate; [1]

perboric acid, sodium salt; [2]

perboric acid, sodium salt, monohydrate; [3]

sodium peroxometaborate; [4]

perboric acid (HBO(O2)), sodium salt, monohydrate; [5]

sodium peroxoborate;

[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

E

239-172-9 [1]

234-390-0 [2]

- [3]

231-556-4 [4]

- [5]

15120-21-5 [1]

11138-47-9 [2]

12040-72-1 [3]

7632-04-4 [4]

10332-33-9 [5]

O; R8

Repr. Cat. 2; R61

Repr. Cat. 3; R62

T; R23

Xn; R22

Xi; R37-41

O; T

R: 61-8-22-23-37-41-62

S: 53-45

C ≥ 25 %: T; R61-22-23-37-41-62

22 % ≤ C < 25 %: T; R61-20-37-41-62

20 % ≤ C < 22 %: T; R61-20-36/37-62

14 % ≤ C < 20 %: T; R61-20-36-62

9 % ≤ C < 14 %: T; R61-20-62

6,5 % ≤ C < 9 %: T; R61-20

3 % ≤ C < 6,5 %: Xn; R20

005-018-00-2

perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]

perboric acid, sodium salt, tetrahydrate; [2]

perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]

sodium peroxoborate hexahydrate;

[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

- [1]

- [2]

- [3]

13517-20-9 [1]

37244-98-7 [2]

10486-00-7 [3]

Repr. Cat. 2; R61

Repr. Cat. 3; R62

Xi; R37-41

T

R: 61-37-41-62

S: 53-45-47

C ≥ 36 %: T; R61-37-41-62

22 % ≤ C < 36 %: T; R61-36/37-62

20 % ≤ C < 22 %: T; R61-37-62

14 % ≤ C < 20 %: T; R61-62

10 % ≤ C < 14 %: T; R61

005-018-01-X

perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1]

perboric acid, sodium salt, tetrahydrate; [2]

perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]

sodium peroxoborate hexahydrate;

[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

E

- [1]

- [2]

- [3]

13517-20-9 [1]

37244-98-7 [2]

10486-00-7 [3]

Repr. Cat. 2; R61

Repr. Cat. 3; R62

Xn; R20

Xi; R37-41

T

R: 61-20-37-41-62

S: 53-45-47

C ≥ 36 %: T; R61-20-37-41-62

25 % ≤ C < 36 %: T; R61-20-36/37-62

22 % ≤ C < 25 %: T; R61-36/37-62

20 % ≤ C < 22 %: T; R61-37-62

14 % ≤ C < 20 %: T; R61-62

10 % ≤ C < 14 %: T; R61

006-097-00-61-phenyl-3-(p-toluenesulfonyl)urea424-620-113909-63-2

Xn; R22-48/22

R52-53

Xn

R: 22-48/22-52/53

S: (2-)22-36-61

006-098-00-1 tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate429-170-8134575-17-0

Xn; R22-48/22

Xi; R41

R43

Xn

R: 22-41-43-48/22

S: (2-)22-26-36/37/39

006-099-00-7

N-(p-toluenesulfonyl)-N′-(3-(p-toluenesulfonyloxy)phenyl)urea;

3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzenesulfonate

432-520-2232938-43-1N; R51-53

N

R: 51/53

S: 22-61

006-101-00-6

mixture of: N,N″-(methylenedi-4,1-phenylene)bis[N′-phenylurea];

N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N′-cyclohexylurea;

N,N″-(methylenedi-4,1-phenylene)bis[N′-cyclohexylurea]

423-070-8—R53

R: 53

S: 61

006-102-00-1 O-hexyl-N-ethoxycarbonylthiocarbamateE432-750-3—

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Xn; R22-48/22

R43

N; R51-53

T; N

R: 45-46-22-43-48/22-51/53

S: 53-45-61

006-103-00-7 N,N″-(methylenedi-4,1-phenylene)bis[N′-octyl]urea445-760-8—

Xi; R41

R42

N; R50-53

Xn; N

R: 41-42-50/53

S: (2-)22-26-39-45-60-61

C ≥10 %: Xn, N; R41-42-50/53

5 % ≤ C < 10 %: Xn, N; R36-42-50/53

1 % ≤ C < 5 %: Xn, N; R42-50/53

0,25 % ≤ C < 1 %: N; R50/53

0,025 % ≤ C < 0,25 %: N; R51/53

0,0025 ≤ C < 0,025 %: R52/53

007-029-00-8diethyldimethylammonium hydroxide419-400-595500-19-9

Xn; R21/22

C; R35

C

R: 21/22-35

S: (1/2-)26-36/37/39-45

012-004-00-Xaluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate422-150-1—N; R50-53

N

R: 50/53

S: 60-61

014-036-00-X(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane405-020-7105024-66-6

Repr.Cat.2; R60

N; R50-53

T; N

R: 60-50/53

S: 53-45-60-61

C ≥ 0,5 %: T, N; R60-50/53

0,025 % ≤ C < 0,5 %: N; R50/53

0,0025 % ≤ C < 0,025 %: N; R51/53

0,00025 % ≤ C < 0,0025 %: R52/53

014-037-00-52-butanone-O,O′,O′′-(phenylsilylidyne)trioxime433-360-634036-80-1

Xn; R48/22

R43

R52-53

Xn

R: 43-48/22-52/53

S: (2-)36/37-61

014-038-00-0 S-(3-(triethoxysilyl)propyl)octanethioate436-690-9220727-26-4R43

Xi

R: 43

S: (2-)24-37

014-039-00-6(2,3-dimethylbut-2-yl)-trimethoxysilane439-360-2142877-45-0

Xi; R38-41

R52-53

Xi

R: 38-41-52/53

S: (2-)26-37/39-61

014-041-00-7 N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane445-890-5201290-01-9

Xn; R22

R43

Xn

R: 22-43

S: (2-)24-37

014-042-00-2mixture of: O,O′,O″,O′′′-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)423-010-0—Xi; R41

Xi

R: 41

S: (2-)26-39

014-043-00-8reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)432-200-2—

F; R11

Xi; R37/38-41

R52-53

F; Xi

R: 11-37/38-41-52/53

S: (2-)6-26-36/39-61

014-044-00-33-[(4′-acetoxy-3′-methoxyphenyl) propyl]trimethoxysilane433-050-0—N; R51-53

N

R: 51/53

S: 61

014-045-00-9magnesium sodium fluoride silicate442-650-1—Xn; R48/20

Xn

R: 48/20

S: (2-)22-36

015-190-00-0

bis(2,4-dicumylphenyl) neopentyl diphosphite;

3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane

421-920-2154862-43-8R53

R: 53

S: 61

015-191-00-6dodecyldiphenyl phosphate431-760-527460-02-2

Xi; R38

R52-53

Xi

R: 38-52/53

S: (2-)37-61

015-192-00-1tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate432-770-2139189-30-3

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

015-193-00-7triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)442-960-7332350-93-3

T; R25

Xi; R41

N; R50-53

T; N

R: 25-41-50/53

S: (1/2-)26-39-45-60-61

015-194-00-2tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate444-440-5220689-12-3

Xn; R22

R52-53

Xn

R: 22-52/53

S: (2-)61

015-195-00-8

mixture of: potassium o-toluenephosphonate;

potassium m-toluenephosphonate;

potassium p-toluenephosphonate

433-860-4—

Xi; R36

R43

R52-53

Xi

R: 36-43-52/53

S: (2-)24-26-37-61

015-196-00-3

mixture of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;

diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;

methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate

435-960-3—

Carc.Cat.2; R45

Muta.Cat.2; R46

R43

T

R: 45-46-43

S: 53-45

015-197-00-9bis(2,4,4-trimethylpentyl)dithiophosphonic acid420-160-9107667-02-7

R10

T; R23

Xn; R22

C; R34

N; R51-53

T; N

R: 10-22-23-34-51/53

S: (1/2-)9-26-36/37/39-45-61

015-198-00-4(4-phenylbutyl)phosphinic acid420-450-586552-32-1

Carc.Cat.3; R40

Xi; R41

Xn

R: 40-41

S: (2-)23-26-36/37/39

016-094-00-1sulfur231-722-67704-34-9Xi; R38

Xi

R: 38

S: (2-)46

016-097-00-81-amino-2-methyl-2-propanethiol hydrochloride434-480-132047-53-3

Xn; R22

C; R34

R43

R52-53

C

R: 22-34-43-52/53

S: (1/2-)22-26-36/37/39-45-61

017-009-01-8

ammonium perchlorate;

[containing < 80 % of 0-30 μm particles]

T232-235-17790-98-9

E; R2

O; R9

E

R: 2-9

S: (2-)14-16-36/37

022-004-00-1potassium titanium oxide (K2Ti6O13)432-240-012056-51-8Carc.Cat.3; R40

Xn

R: 40

S: (2-)22-36/37

022-005-00-7[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium419-840-8169104-71-6

F; R11

C; R34

R43

R53

F; C

R: 11-34-43-53

S: (1/2-)6-9-16-26-36/37/39-45-61

028-002-01-4

nickel powder;

[particle diameter < 1 mm]

231-111-47440-02-0

Carc. Cat. 3; R40

T; R48/23

R43

R52-53

T

R: 40-43-48/23-52/53

S: (2-)36/37/39-45-61

028-013-00-7nickel matteE, H273-749-669012-50-6

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-014-00-2slimes and sludges, copper electrolytic refining, decopperised, nickel sulfateE295-859-392129-57-2

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

Xn; R20/22

Xi; R38

R42/43

N; R50-53

T; N

R: 49-61-20/22-38-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-20/22-38-42/43-48/23-68-50/53

20 % ≤ C < 25 %: T, N; R49-61-38-42/43-48/23-68-51/53

2,5 % ≤ C < 20 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-015-00-8slimes and sludges, copper electrolyte refining, decopperisedE, H305-433-194551-87-8

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 1; R61

Repr. Cat. 3; R62

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-62-68-50/53

S: 53-45-60-61

028-016-00-3

nickel diperchlorate;

perchloric acid, nickel(II) salt

E, H237-124-113637-71-3

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

C; R34

R42/43

N; R50-53

T; N

R: 49-61-34-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-34-42/43-48/23-68-50/53

5 % ≤ C < 25 %: T, N; R49-61-34-42/43-48/23-68-51/53

2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-017-00-9

nickel dipotassium bis(sulfate); [1]

diammonium nickel bis(sulfate) [2]

E, H

237-563-9 [1]

239-793-2 [2]

13842-46-1 [1]

15699-18-0 [2]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

Xn; R20/22

R42/43

N; R50-53

T; N

R: 49-61-20/22-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-018-00-4

nickel bis(sulfamidate);

nickel sulfamate

E, H237-396-113770-89-3

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-019-00-Xnickel bis(tetrafluoroborate)E, H238-753-414708-14-6

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-021-00-0

nickel diformate; [1]

formic acid, nickel salt; [2]

formic acid, copper nickel salt [3]

E, H

222-101-0 [1]

239-946-6 [2]

268-755-0 [3]

3349-06-2 [1]

15843-02-4 [2]

68134-59-8 [3]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5%: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C 0,1 %: Xi; R43

028-022-00-6

nickel di(acetate); [1]

nickel acetate [2]

E, H

206-761-7 [1]

239-086-1 [2]

373-02-4 [1]

14998-37-9 [2]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

Xn; R20/22

R42/43

N; R50-53

T; N

R: 49-61-20/22-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-024-00-7nickel dibenzoateE, H209-046-8553-71-9

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-025-00-2nickel bis(4-cyclohexylbutyrate)E, H223-463-23906-55-6

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-026-00-8

nickel(II) stearate;

nickel(II) octadecanoate

E, H218-744-12223-95-2

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-027-00-3nickel dilactateE, H—16039-61-5

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-028-00-9nickel(II) octanoateE, H225-656-74995-91-9

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat 2; R61

T; R48/23

C; R35

R42/43

N; R50-53

T; C; N

R: 49-61-35-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, C, N; R49-61-35-42/43-48/23-68-50/53

10 % ≤ C < 25 %: T, C, N; R49-61-35-42/43-48/23-68-51/53

5 % ≤ C < 10 %: T, N; R49-61-34-42/43-48/23-68-51/53

2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-029-00-4

nickel difluoride; [1]

nickel dibromide; [2]

nickel diiodide; [3]

nickel potassium fluoride [4]

E, H

233-071-3 [1]

236-665-0 [2]

236-666-6 [3]

- [4]

10028-18-9 [1]

13462-88-9 [2]

13462-90-3 [3]

11132-10-8 [4]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; 49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; 49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-030-00-Xnickel hexafluorosilicateE, H247-430-726043-11-8

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-031-00-5nickel selenateE, H239-125-215060-62-5

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-032-00-0

nickel hydrogen phosphate; [1]

nickel bis(dihydrogen phosphate); [2]

trinickel bis(orthophosphate); [3]

dinickel diphosphate; [4]

nickel bis(phosphinate); [5]

nickel phosphinate; [6]

phosphoric acid, calcium nickel salt; [7]

diphosphoric acid, nickel(II) salt [8]

E, H

238-278-2 [1]

242-522-3 [2]

233-844-5 [3]

238-426-6 [4]

238-511-8 [5]

252-840-4 [6]

- [7]

- [8]

14332-34-4 [1]

18718-11-1 [2]

10381-36-9 [3]

14448-18-1 [4]

14507-36-9 [5]

36026-88-7 [6]

17169-61-8 [7]

19372-20-4 [8]

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

028-033-00-6diammonium nickel hexacyanoferrateE, H—74195-78-1

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

028-034-00-1nickel dicyanideE, H209-160-8557-19-7

Carc. Cat. 1; R49

T; R48/23

R42/43

R32

N; R50-53

T; N

R: 49-32-42/43-48/23-50/53

S: 53-45-60-61

028-035-00-7nickel chromateE, H238-766-514721-18-7

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

028-036-00-2

nickel(II) silicate; [1]

dinickel orthosilicate; [2]

nickel silicate (3:4); [3]

silicic acid, nickel salt; [4]

trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5]

E, H

244-578-4 [1]

237-411-1 [2]

250-788-7 [3]

253-461-7 [4]

235-688-3 [5]

21784-78-1 [1]

13775-54-7 [2]

31748-25-1 [3]

37321-15-6 [4]

12519-85-6 [5]

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-037-00-8dinickel hexacyanoferrateE, H238-946-314874-78-3

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-038-00-3

trinickel bis(arsenate);

nickel(II) arsenate

E, H236-771-713477-70-8

Carc. Cat. 1; R45

T; R48/23

R43

N; R50-53

T; N

R: 45-43-48/23-50/53

S: 53-45-60-61

028-039-00-9

nickel oxalate; [1]

oxalic acid, nickel salt [2]

E, H

208-933-7 [1]

243-867-2 [2]

547-67-1 [1]

20543-06-0 [2]

Carc. Cat. 1; R49

T; R48/23

R43

N: R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-040-00-4nickel tellurideE, H235-260-612142-88-0

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-041-00-Xtrinickel tetrasulfideE, H—12137-12-1

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-042-00-5trinickel bis(arsenite)E, H—74646-29-0

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-043-00-0

cobalt nickel gray periclase;

C.I. Pigment Black 25;

C.I. 77332; [1]

cobalt nickel dioxide; [2]

cobalt nickel oxide [3]

E, H

269-051-6 [1]

261-346-8 [2]

- [3]

68186-89-0 [1]

58591-45-0 [2]

12737-30-3 [3]

Carc. Cat. 1; R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

028-044-00-6

nickel tin trioxide;

nickel stannate

E, H234-824-912035-38-0

Carc. Cat. 1; R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

028-045-00-1nickel triuranium decaoxideE, H239-876-615780-33-3

Carc. Cat. 1; R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

028-046-00-7nickel dithiocyanateE, H237-205-113689-92-4

Carc. Cat. 1; R49

Muta. Cat. 3;R68

Repr. Cat. 2; R61

T; R48/23

R42/43

R32

N; R50-53

T; N

R: 49-61-32-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T: R49-61-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-047-00-2nickel dichromateE, H239-646-515586-38-6

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1% ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C 0,1 %: Xi; R43

028-048-00-8nickel(II) seleniteE, H233-263-710101-96-9

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

028-049-00-3nickel selenideE, H215-216-21314-05-2

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-050-00-9silicic acid, lead nickel saltE, H—68130-19-8

Carc. Cat. 1: R49

Repr. Cat. 1: R61

Repr. Cat. 3; R62

T; R48/23

R43

N; R50-53

T; N

R: 49-61-43-48/23-62-50/53

S: 53-45-60-61

028-051-00-4

nickel diarsenide; [1]

nickel arsenide [2]

E, H

235-103-1 [1]

248-169-1 [2]

12068-61-0 [1]

27016-75-7 [2]

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-052-00-X

nickel barium titanium primrose priderite;

C.I. Pigment Yellow 157;

C.I. 77900

E, H271-853-668610-24-2

Carc. Cat. 1: R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

028-053-00-5

nickel dichlorate; [1]

nickel dibromate; [2]

ethyl hydrogen sulfate, nickel(II) salt [3]

E, H

267-897-0 [1]

238-596-1 [2]

275-897-7 [3]

67952-43-6 [1]

14550-87-9 [2]

71720-48-4 [3]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T: R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T: R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-054-00-0

nickel(II) trifluoroacetate; [1]

nickel(II) propionate; [2]

nickel bis(benzenesulfonate); [3]

nickel(II) hydrogen citrate; [4]

citric acid, ammonium nickel salt; [5]

citric acid, nickel salt; [6]

nickel bis(2-ethylhexanoate); [7]

2-ethylhexanoic acid, nickel salt; [8]

dimethylhexanoic acid nickel salt; [9]

nickel(II) isooctanoate; [10]

nickel isooctanoate; [11]

nickel bis(isononanoate); [12]

nickel(II) neononanoate; [13]

nickel(II) isodecanoate; [14]

nickel(II) neodecanoate; [15]

neodecanoic acid, nickel salt; [16]

nickel(II) neoundecanoate; [17]

bis(D-gluconato-O 1,O 2)nickel; [18]

nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19]

nickel(II) palmitate; [20]

(2-ethylhexanoato-O)(isononanoato-O)nickel; [21]

(isononanoato-O)(isooctanoato-O)nickel; [22]

(isooctanoato-O)(neodecanoato-O)nickel; [23]

(2-ethylhexanoato-O)(isodecanoato-O)nickel; [24]

(2-ethylhexanoato-O)(neodecanoato-O)nickel; [25]

(isodecanoato-O)(isooctanoato-O)nickel; [26]

(isodecanoato-O)(isononanoato-O)nickel; [27]

(isononanoato-O)(neodecanoato-O)nickel; [28]

fatty acids, C6-19-branched, nickel salts; [29]

fatty acids, C8-18 and C18-unsaturated, nickel salts; [30]

2,7-naphthalenedisulfonic acid, nickel(II) salt; [31]

E, H

240-235-8 [1]

222-102-6 [2]

254-642-3 [3]

242-533-3 [4]

242-161-1 [5]

245-119-0 [6]

224-699-9 [7]

231-480-1 [8]

301-323-2 [9]

249-555-2 [10]

248-585-3 [11]

284-349-6 [12]

300-094-6 [13]

287-468-1 [14]

287-469-7 [15]

257-447-1 [16]

300-093-0 [17]

276-205-6 [18]

258-051-1 [19]

237-138-8 [20]

287-470-2 [21]

287-471-8 [22]

284-347-5 [23]

284-351-7 [24]

285-698-7 [25]

285-909-2 [26]

284-348-0 [27]

287-592-6 [28]

294-302-1 [29]

283-972-0 [30]

- [31]

16083-14-0 [1]

3349-08-4 [2]

39819-65-3 [3]

18721-51-2 [4]

18283-82-4 [5]

22605-92-1 [6]

4454-16-4 [7]

7580-31-6 [8]

93983-68-7 [9]

29317-63-3 [10]

27637-46-3 [11]

84852-37-9 [12]

93920-10-6 [13]

85508-43-6 [14]

85508-44-7 [15]

51818-56-5 [16]

93920-09-3 [17]

71957-07-8 [18]

52625-25-9 [19]

13654-40-5 [20]

85508-45-8 [21]

85508-46-9 [22]

84852-35-7 [23]

84852-39-1 [24]

85135-77-9 [25]

85166-19-4 [26]

84852-36-8 [27]

85551-28-6 [28]

91697-41-5 [29]

84776-45-4 [30]

72319-19-8 [31]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-055-00-6

nickel(II) sulfite; [1]

nickel tellurium trioxide; [2]

nickel tellurium tetraoxide; [3]

molybdenum nickel hydroxide oxide phosphate [4]

E, H

231-827-7 [1]

239-967-0 [2]

239-974-9 [3]

268-585-7 [4]

7757-95-1 [1]

15851-52-2 [2]

15852-21-8 [3]

68130-36-9 [4]

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

028-056-00-1

nickel boride (NiB); [1]

dinickel boride; [2]

trinickel boride; [3]

nickel boride; [4]

dinickel silicide; [5]

nickel disilicide; [6]

dinickel phosphide; [7]

nickel boron phosphide [8]

E, H

234-493-0 [1]

234-494-6 [2]

234-495-1 [3]

235-723-2 [4]

235-033-1 [5]

235-379-3 [6]

234-828-0 [7]

- [8]

12007-00-0 [1]

12007-01-1 [2]

12007-02-2 [3]

12619-90-8 [4]

12059-14-2 [5]

12201-89-7 [6]

12035-64-2 [7]

65229-23-4 [8]

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-057-00-7

dialuminium nickel tetraoxide; [1]

nickel titanium trioxide; [2]

nickel titanium oxide; [3]

nickel divanadium hexaoxide; [4]

cobalt dimolybdenum nickel octaoxide; [5]

nickel zirkonium trioxide; [6]

molybdenum nickel tetraoxide; [7]

nickel tungsten tetraoxide; [8]

olivine, nickel green; [9]

lithium nickel dioxide; [10]

molybdenum nickel oxide; [11]

E, H

234-454-8 [1]

234-825-4 [2]

235-752-0 [3]

257-970-5 [4]

268-169-5 [5]

274-755-1 [6]

238-034-5 [7]

238-032-4 [8]

271-112-7 [9]

- [10]

- [11]

12004-35-2 [1]

12035-39-1 [2]

12653-76-8 [3]

52502-12-2 [4]

68016-03-5 [5]

70692-93-2 [6]

14177-55-0 [7]

14177-51-6 [8]

68515-84-4 [9]

12031-65-1 [10]

12673-58-4 [11]

Carc. Cat. 1; R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

028-058-00-2cobalt lithium nickel oxideE442-750-5—

Carc. Cat. 1; R49

T+; R26

T; R48/23

R43

N; R50-53

T+; N

R: 49-26-43-48/23-50/53

S: 53-45-60-61

029-014-00-5

mixture of: 2,2′-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N,N′,O,O′-copper complex;

2,2′-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N,N′,O,O′-copper complex

419-610-7171866-24-3

Xn; R48/22

N; R51-53

Xn; N

R: 48/22-51/53

S: (2-)22-36-61

030-012-00-1aluminium-magnesium-zinc-carbonate-hydroxide423-570-6169314-88-9R52-53

R: 52/53

S: 61

030-015-00-8tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate440-060-9—N; R51-53

N

R: 51/53

S: 61

042-005-00-0

mixture of: mono- and di-glycerols of canola oil;

canola oil acid amide of branched 1,3-propanediamine,N-[3-(tridecyloxy)-propyl];

N,N-diorgano dithiocarbamate molybdenum complex

434-240-6—

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

050-023-00-5

mixture of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane;

bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide;

bis(1-phenyl-1,3-decanedionyl)dioctyl stannane;

((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane

422-920-5—

Xn; R48/22

N; R50-53

Xn; N

R: 48/22-50/53

S: (2-)23-36-60-61

C ≥ 10 %: Xn, N; R48/22-50/53

2,5 % ≤ C < 10 %: N; R50/53

0,25 % ≤ C < 2,5 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

050-024-00-0

mixture of: tri-p-tolyltin hydroxide;

hexa-p-tolyl-distannoxane

432-230-6—

T; R48/25

Xn; R22

Xi; R38-41

R43

N; R50-53

T; N

R: 22-38-41-43-48/25-50/53

S: (1/2-)22-26-36/37/39-45-60-61

064-001-00-8gadolinium(III)sulfite trihydrate456-900-251285-81-5N; R51-53

N

R: 51/53

S: 61

078-011-00-5hydroxydisulfito platinum(II) acid423-310-161420-92-6

Xn; R22-48/20/21/22

C; R35

R42/43

R52-53

C

R: 22-35-42/43-48/20/21/22-52/53

S: (1/2-)23-24-26-28-36/37/39-45-61

078-012-00-0platinum(IV) nitrate/nitric acid solution432-400-1—

C; R35

N; R50-53

C; N

R: 35-50/53

S: (1/2-)26-36/37/39-45-60-61

082-012-00-6barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped431-780-4199876-46-5

Xn; R22-48/22

N; R51-53

Xn; N

R: 22-48/22-51/53

S: (2-)22-36-61

601-080-00-5

mixture of: sec-butylphenyl(phenyl)methane, mixed isomers;

1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers;

1-(sec-butylphenyl-1-phenylethane, mixed isomers

431-100-6—N; R50-53

N

R: 50/53

S: 60-61

601-081-00-0cyclohexadeca-1,9-diene431-730-14277-06-9

Xi; R38

R43

R53

Xi

R: 38-43-53

S: (2-)36/37-61

601-082-00-6

mixture of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane;

exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane

434-420-4—

Xi; R38-41

N; R50-53

Xi; N

R: 38-41-50/53

S: (2-)23-26-37/39-57-60-61

601-083-00-15-endo-hexyl-bicyclo[2.2.1]hept-2-ene435-000-322094-83-3

Xn; R65

Xi; R38

R53

Xn

R: 38-65-53

S: (2-)37-62-61

601-084-00-7

mixture of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene;

5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20)

435-180-3—

Xn; R65

Xi; R38

N; R50-53

Xn; N

R: 38-65-50/53

S: (2-)37-62-60-61

602-105-00-2sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate422-100-7102061-82-5

Xi; R41

R43

Xi

R: 41-43

S: (2-)24-26-37/39

602-106-00-82-bromo-4,6-difluoroaniline429-430-0444-14-4

Xn; R22

N; R51-53

Xn; N

R: 22-51/53

S: (2-)25-61

602-107-00-33,3,4,4-tetrafluoro-4-iodo-1-butene439-500-233831-83-3

Xn; R22

Xi; R38

N; R51-53

Xn; N

R: 22-38-51/53

S: (2-)37-61

602-108-00-9(2,3,5,6-tetrafluorophenyl)methanol443-840-74084-38-2

Xn; R22

Xi; R36

R43

Xn

R: 22-36-43

S: (2-)26-36/37

603-211-00-1

2,3-epoxypropyltrimethylammonium chloride … %;

glycidyl trimethylammonium chloride … %

B E221-221-03033-77-0

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

Xn; R21/22-48/22

Xi; R41

R43

R52-53

T

R: 45-21/22-41-43-48/22-62-68-52/53

S: 53-45-61

603-212-00-7

1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran;

galaxolide;

(HHCB)

214-946-91222-05-5N; R50-53

N

R: 50/53

S: 60-61

603-213-00-2

2-methoxy-2-methylbutane;

tert-amyl methyl ether

213-611-4994-05-8

F; R11

Xn; R22

R67

F; Xn

R: 11-22-67

S: (2-)9-16-23-33

603-214-00-81,1-diisopropoxycyclohexane413-740-81132-95-2C; R34

C

R: 34

S: (1/2-)23-26-36/37/39-45

603-215-00-31-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)418-330-2162241-33-0

E; R2

Xn; R22-48/22

Xi; R41

R43

N; R50-53

E; Xn; N

R: 2-22-41-43-48/22-50/53

S: (2-)22-26-36/37/39-60-61

603-216-00-9 cis-1-amino-2,3-dihydro-1H-inden-2-ol422-660-27480-35-5

Xi; R41

R43

R52-53

Xi

R: 41-43-52/53

S: (2-)24-26-37/39-61

603-217-00-42,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite423-560-1161717-32-4

R43

R53

Xi

R: 43-53

S: (2-)24-37/39-61

603-220-00-01-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol432-890-572955-94-3R53

R: 53

S: 61

603-221-00-6

1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;

[containing < 0,1 % 4-chloroaniline (EC No 203-401-0)]

433-580-2214353-17-0

Xn; R22

C; R34

N; R51-53

C; N

R: 22-34-51/53

S: (1/2-)26-36/37/39-45-61

603-221-01-3

1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;

[containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)]

E433-580-2214353-17-0

Carc. Cat. 2; R45

Xn; R22

C; R34

N; R51-53

T; N

R: 45-22-34-51/53

S: 53-45-61

603-222-00-1(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane433-820-6118058-74-5Xi; R36

Xi

R: 36

S: (2-)26

603-223-00-7

2-cyclopentylidene cyclopentanol;

1,1′-bi(cyclopentyliden)-2-ol

434-270-16261-30-9

Xi; R38-41

R52-53

Xi

R: 38-41-52/53

S: (2-)26-37/39-61

603-224-00-23-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane435-790-1297730-93-9R53

R: 53

S: 61

603-225-00-8

erythromycin A9-oxime (E);

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-D-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)

437-070-013127-18-9N; R51-53

N

R: 51/53

S: 61

603-226-00-34,4′(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol444-500-01440-00-2R52-53

R: 52/53

S: 61

603-227-00-9

α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1);

reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate

445-060-2203574-04-3

O; R7

N; R50-53

O; N

R: 7-50/53

S: (2-)3/7-14-36/37/39-60-61

603-228-00-4

(+/-)-(R*,R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran;

6-fluoro-2-(2-oxiranyl)chromane

419-620-1—

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)36/37-61

603-229-00-Xsodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate420-800-7—

Xi; R38-41

R43

N; R50-53

Xi; N

R: 38-41-43-50/53

S: (2-)24-26-37/39-60-61

603-230-00-52,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan440-030-5—

Xi; R38-41

R53

Xi

R: 38-41-53

S: (2-)26-37/39-61

603-231-00-0(S)-1,1-diphenyl-1,2-propanediol443-220-6—R52-53

R: 52/53

S: 22-61

603-232-00-63,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane444-420-6—R53

R: 53

S: 61

603-233-00-1

mixture of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;

4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;

1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;

1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;

(E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol;

(E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol

444-430-0—N; R51-53

N

R: 51/53

S: 61

603-234-00-7(1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene444-480-3—

Xi; R38

N; R51-53

Xi; N

R: 38-51/53

S: (2-)37-61

604-074-00-0

tetrabromobisphenol-A;

2,2′,6,6′-tetrabromo-4,4′-isopropylidenediphenol

201-236-979-94-7N; R50-53

N

R: 50/53

S: 60-61

604-075-00-6

4-(1,1,3,3-tetramethylbutyl)phenol;

4-tert-octylphenol

205-426-2140-66-9

Xi; R38-41

N; R50-53

Xi; N

R: 38-41-50/53

S: (2-)26-37/39-60-61

C ≥ 20 %: Xi, N; R38-41-50/53

10 % ≤ C < 20 %: Xi, N; R41-50/53

5 % ≤ C < 10 %: Xi, N; R36-50/53

2,5 % ≤ C < 5 %: N; R50/53

0,25 % ≤ C < 2,5 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

604-076-00-1phenolphthalein201-004-777-09-8

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T

R: 45-62-68

S: 53-45

C ≥ 5 %: T; R45-62-68

1 % ≤ C < 5 %: T; R45-68

604-077-00-72-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol419-750-998809-58-6R53

R: 53

S: 61

604-079-00-84,4′-(1,3-phenylene-bis(1-methylethylidene))bis-phenol428-970-413595-25-0

Repr.Cat.3; R62

R43

N; R51-53

Xn; N

R: 43-62-51/53

S: (2-)22-36/37-61

604-080-00-34-fluoro-3-trifluoromethylphenol432-560-061721-07-1

Xn; R20

C; R35

R43

N; R51-53

C; N

R: 20-35-43-51/53

S: (1/2-)26-28-36/37/39-45-61

604-081-00-91,1-bis(4-hydroxyphenyl)-1-phenylethane433-130-51571-75-1N; R50-53

N

R: 50/53

S: 25-60-61

604-082-00-42-chloro-6-fluoro-phenolE433-890-82040-90-6

Muta.Cat.2; R46

Repr.Cat.3; R62

Xn; R22

C; R34

R43

N; R51-53

T; N

R: 46-22-34-43-62-51/53

S: 53-45-61

604-083-00-X4,4′-sulfonylbisphenol, polymer with ammonium chloride(NH4Cl), pentachlorophosphorane and phenol439-270-3260408-02-4R53

R: 53

S: 61

604-084-00-51-ethoxy-2,3-difluorobenzene441-000-4121219-07-6

Xn; R22

R52-53

Xn

R: 22-52/53

S: (2-)23-61

604-087-00-1

mixture of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;

1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;

1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol

433-640-8—

F; R17

R44

R53

F

R: 17-44-53

S: (2-)15-22-61

604-089-00-22-methyl-5-tert-butylthiophenol444-970-7—

R10

Repr.Cat.3; R63

Xn; R48/20/22-65

Xi; R36/38

R43

R67

N; R50-53

Xn; N

R: 10-36/38-43-48/20/22-63-65-67-50/53

S: (2-)26-36/37-62-60-61

605-037-00-1

trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde;

3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde

421-800-1120578-03-2R53

R: 53

S: 22-61

605-038-00-73-methyl-5-phenylpentan-1-al433-900-055066-49-4

Xn; R22

Xi; R38

R43

N; R51-53

Xn; N

R: 22-38-43-51/53

S: (2-)36/37-61

605-039-00-23,4-dihydroxy-5-nitrobenzaldehyde441-810-8116313-85-0

Xn; R22

Xi; R41

R43

Xn

R: 22-41-43

S: (2-)22-24-26-37/39

606-124-00-71-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione421-080-7161462-35-7

Xn; R48/22

N; R50-53

Xn; N

R: 48/22-50/53

S: (2-)36-60-61

606-125-00-21-benzylimidazolidine-2,4-dione421-340-16777-05-5Xn; R22

Xn

R: 22

S: (2-)22

606-126-00-81,4-bis(2,3-dihydroxypropylamino)anthraquinone421-470-799788-75-7N; R51-53

N

R: 51/53

S: 61

606-128-00-92,2′-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione422-650-8148935-94-8R53

R: 53

S: 61

606-129-00-4

5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one;

(2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one

423-090-7156732-13-7R53

R: 53

S: 61

606-130-00-X4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone423-860-256309-94-5

R43

R52-53

Xi

R: 43-52/53

S: (2-)24-37-61

606-131-00-5cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dioneE427-230-85571-36-8

Repr. Cat. 2; R60

Xn; R48/22

N; R51-53

T; N

R: 60-48/22-51/53

S: 53-45-61

606-132-00-0(6β)-6,19-epoxyandrost-4-ene-3,17-dione433-490-36563-83-3

R43

R52-53

Xi

R: 43-52/53

S: (2-)24-37-61

606-134-00-1androsta-1,4,9(11)-triene-3,17-dione433-560-315375-21-0Repr. Cat.3; R62

Xn

R: 62

S: (2-)22-36/37

606-135-00-7cyclohexadecanone438-930-82550-52-9R53

R: 53

S: 61

606-136-00-2(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone444-350-6133413-70-4

Xi; R36

R53

Xi

R: 36-53

S: (2-)26-61

606-137-00-8 trans-7,7′-dimethyl-(4H,4H′)-(2,2′)bi[benzo[1,4]thiazinylidene]-3,3′-dione444-750-0211387-26-7R53

R: 53

S: 22-61

606-138-00-3(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone444-800-1141645-23-0

R10

Xn; R22-48/22

Xi; R38-41

R43

N; R50-53

Xn; N

R: 10-22-38-41-43-48/22-50/53

S: (2-)23-26-36/37/39-60-61

C ≥ 25 %: Xn, N; R22-38-41-43-48/22-50/53

20 % ≤ C < 25 %: Xn, N; R38-41-43-48/22-50/53

10 % ≤ C < 20 %: Xn, N; R41-43-48/22-50/53

5 % ≤ C < 10 %: Xi, N; R36-43-50/53

2,5 % ≤ C < 5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

606-139-00-9(S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one444-830-5124379-29-9R53

R: 53

S: 61

606-140-00-42-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one444-860-9474510-57-1

Xn; R48/22

N; R50-53

Xn; N

R: 48/22-50/53

S: (2-)22-36-60-61

606-141-00-Xsodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate418-410-7—Xi; R36

Xi

R: 36

S: (2-)26

606-142-00-5

mixture of: (1RS,2SR,7SR,8SR,E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;

(1RS,2SR,7SR,8SR,Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;

(1RS,2SR,7SR,8SR,Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one

434-290-9—

Xn; R22

N; R51-53

Xn; N

R: 22-51/53

S: (2-)61

607-580-00-Xethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate422-360-1100491-29-0

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)22-24-37-61

607-618-00-5

menadione sodium bisulfite;

2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt

204-987-0130-37-0

Xi; R36/38

N; R50-53

Xi; N

R: 36/38-50/53

S: (2-)24/25-60-61

607-619-00-0

menadione nicotinamide bisulfite;

1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1)

277-543-773581-79-0

Xi; R36/38

N; R50-53

Xi; N

R: 36/38-50/53

S: (2-)24/25-60-61

607-620-00-6trisodium nitrilotriacetate225-768-65064-31-3

Carc. Cat. 3; R40

Xn; R22

Xi; R36

Xn

R: 22-36-40

S: (2-)26-36/37-46

C ≥ 25 %: Xn; R22-36-40

20 ≤ % C < 25 %: Xn; R36-40

5 ≤ % C < 20 %: Xn; R40

607-621-00-1

milbemectin (ISO);

[mixture of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)]

——

Xn; R20/22

N; R50-53

Xn; N

R: 20/22-50/53

S: (2-)46-60-61

C ≥ 25 %: Xn, N; R20/22-50/53

0,25 % ≤ C < 25 %: N; R50/53

0,025 % ≤ C < 0,25 %: N; R51/53

0,0025 % ≤ C < 0,025 %: R52/53

607-622-00-72-ethylhexyl-2-ethylhexanoate231-057-17425-14-1Repr. Cat. 3; R63

Xn

R: 63

S: (2-)36/37

607-623-00-2diisobutyl phthalate201-553-284-69-5

Repr. Cat. 2; R61

Repr. Cat. 3; R62

T

R: 61-62

S: 53-45

C ≥ 25 %: T; R61-62

5 % ≤ C < 25 %: Xn; R62

607-624-00-8

perfluorooctane sulfonic acid;

heptadecafluorooctane-1-sulfonic acid; [1]

potassium perfluorooctanesulfonate;

potassium heptadecafluorooctane-1-sulfonate; [2]

diethanolamine perfluorooctane sulfonate; [3]

ammonium perfluorooctane sulfonate;

ammonium heptadecafluorooctanesulfonate; [4]

lithium perfluorooctane sulfonate;

lithium heptadecafluorooctanesulfonate [5]

E

217-179-8 [1]

220-527-1 [2]

274-460-8 [3]

249-415-0 [4]

249-644-6 [5]

1763-23-1 [1]

2795-39-3 [2]

70225-14-8 [3]

29081-56-9 [4]

29457-72-5 [5]

Carc. Cat. 3; R40

Repr. Cat. 2; R61

T; R48/25

Xn; R20/22

R64

N; R51-53

T; N

R: 61-20/22-40-48/25-64-51/53

S: 53-45-61

607-625-00-3clodinafop-propargyl (ISO)—105512-06-9

Xn; R22-48/22

R43

N; R50-53.

Xn; N

R: 22-43-48/22-50/53

S: (2-)24-36/37-46-60-61

C ≥ 25 %: Xn, N; R22-43-48/22-50/53

10 % ≤ C < 25 %: Xn, N; R43-48/22-51/53

2,5 % ≤ C < 10 %: Xi, N; R43-51/53

0,25 % ≤ C < 2,5 %: Xi; R43-52/53

0,001 % ≤ C < 0,25 %: Xi; R43

607-626-00-9ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate401-290-5103112-35-2

Carc.Cat.2; R45

N; R50-53

T; N

R: 45-50/53

S: 53-45-60-61

607-627-00-4[(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate416-360-0162221-28-5R43

Xi

R: 43

S: (2-)22-24-37

607-628-00-X4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine419-240-6171054-89-0Xi; R41

Xi

R: 41

S: (2-)26-39

607-629-00-5[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid419-270-1123599-82-6Xi; R36

Xi

R: 36

S: (2-)26

607-630-00-0acrylic acid, 3-(trimethoxysilyl)propyl ester419-560-64369-14-6

Xn; R20

C; R34

R43

R52-53

C

R: 20-34-43-52/53

S: (1/2-)26-36/37/39-45-61

607-631-00-6

mixture of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate;

(2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate

442-300-8—R43

Xi

R: 43

S: (2-)24-37

607-632-00-1 N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide420-210-1111244-14-5R53

R: 53

S: 61

607-633-00-7trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate440-480-2341026-59-3

Xi; R41

R43

Xi

R: 41-43

S: (2-)22-24-26-37/39

607-634-00-2

(S)-(-)-2-acetoxypropionylchloride;

(1S)-2-chloro-1-methyl-2-oxoethyl acetate

420-610-436394-75-9

Xn; R22

C; R34

R43

C

R: 22-34-43

S: (1/2-)23-26-36/37/39-45

607-635-00-8trisodium N-(3-propionato)-L-aspartate422-090-4172737-80-3Xi; R41

Xi

R: 41

S: (2-)26-39

607-636-00-31-bromo-2-methylpropyl propionate422-900-6158894-67-8

R10

Carc.Cat.3; R40

C; R34

R43

C

R: 10-34-40-43

S: (1/2-)7/9-8-23-26-36/37/39-45

607-637-00-9disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate423-730-5250688-43-8Xi; R41

Xi

R: 41

S: (2-)26-39

607-638-00-42-hydroxybenzoic acid 2-butyloctyl ester431-090-3190085-41-7R53

R: 53

S: 61

607-639-00-X2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate431-770-1216698-07-6R53

R: 53

S: 61

607-641-00-0

2-(formylamino)-3-thiophenecarboxylic acid;

2-formamido-3-thiophenecarboxylic acid

431-930-943028-69-9

Xn; R22

R43

Xn

R: 22-43

S: (2-)22-24-37

607-642-00-63,6,9-trithiaundecamethylene-1,11-dimethacrylate432-210-7141631-22-3N; R50-53

N

R: 50/53

S: 60-61

607-643-00-1dimethyl (2S)-2-hydroxysuccinate432-310-0617-55-0

R10

Xi; R41

R43

Xi

R: 10-41-43

S: (2-)24-26-37/39-43

607-644-00-7methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate432-350-981752-87-6Xi; R38

Xi

R: 38

S: (2-)37

607-645-00-2tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate432-550-6243858-01-7Xi; R41

Xi

R: 41

S: (2-)22-26-39

607-646-00-8

D-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester;

tert-butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate

432-960-5124655-09-0Xn; R22

Xn

R: 22

S: (2-)25

607-647-00-35-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolane433-530-1143446-73-5

Xn; R22

R43

N; R50

Xn; N

R: 22-43-50

S: (2-)24-37-57-61

607-649-00-4[3-(chlorocarbonyl)-2-methylphenyl]acetate433-690-0167678-46-8

C; R35

R43

C

R: 35-43

S: (1/2-)7/8-26-36/37/39-45

607-650-00-X2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate433-910-5145153-52-2R43

Xi

R: 43

S: (2-)24-37

607-651-00-5sodium 2-(nonanoyloxy)benzenesulfonate434-360-991125-43-8

Xi; R41

R43

Xi

R: 41-43

S: (2-)24-26-37/39

607-652-00-0ethyl N 2-dodecanoyl-L-argininate hydrochloride434-630-660372-77-2

Xi; R41

N; R50

Xi; N

R: 41-50

S: (2-)26-39-61

607-653-00-6tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate434-840-8225786-91-4N; R51-53

N

R: 51/53

S: 61

607-654-00-1(S)-3-hydroxy-γ-butyrolactone434-990-47331-52-4R43

Xi

R: 43

S: (2-)23-24-37

607-655-00-7ethyl 6,8-dichlorooctanoate435-080-11070-64-0

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

607-656-00-2sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid435-350-7141250-43-3

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)22-26-39-61

607-657-00-8pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate436-920-8172399-10-9Xi; R41

Xi

R: 41

S: (2-)22-26-39

607-658-00-33,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt440-770-9371921-63-0

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)26-39-61

607-659-00-9pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid442-030-0321912-47-4Xi; R41

Xi

R: 41

S: (2-)22-26-39

607-660-00-42-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt442-230-8321679-52-1Xi; R41

Xi

R: 41

S: (2-)22-26-39

607-661-00-X1,1-dimethylethyl 4′-(bromomethyl)biphenyl-2-carboxylate442-850-9114772-40-6

R43

R53

Xi

R: 43-53

S: (2-)22-24-37-61

607-662-00-5methyl 2-(acetylamino)-3-chloropropionate442-860-387333-22-0

R43

N; R50-53

Xi; N

R: 43-50/53

S: (2-)24-37-60-61

607-663-00-0bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate442-980-6127474-91-3R53

R: 53

S: 61

607-664-00-6methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate443-120-2393509-79-0

Xi; R41

N; R51-53

Xi; N

R: 41-51/53

S: (2-)26-39-61

607-665-00-1 trans-methyl-2-ethyl-but-2-enoate443-150-6101226-85-1R10

R: 10

S: 23

607-666-00-7(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid443-560-588784-33-2Xi; R36

Xi

R: 36

S: (2-)26

607-667-00-2chloro-1-ethylcyclohexyl carbonate444-950-899464-83-2

Muta.Cat.3; R68

R43

Xn

R: 43-68

S: (2-)23-36/37

607-668-00-8 trans-2-isopropyl-5-carboxy-1,3-dioxane445-770-242031-28-7

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)22-26-39-61

607-669-00-3methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate445-990-9376588-17-9

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

607-670-00-9

dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate;

(5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate

448-700-9500791-70-8

Xn; R48/22

Xi; R41

R43

N; R50-53

Xn; N

R: 41-43-48/22-50/53

S: (2-)22-26-36/37/39-60-61

C ≥ 10 %: Xn, N; R41-43-48/22-50/53

5 % ≤ C < 10 %: Xi, N; R36-43-50/53

2,5 % ≤ C < 5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

607-671-00-4diethyl 1,4-cyclohexanedicarboxylate417-310-072903-27-6N; R51-53

N

R: 51/53

S: 61

607-672-00-X

mixture of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate;

1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate;

x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate

419-000-0—

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

607-673-00-51-ethyl-5,6,7,8-tetrahydroquinolinium tosylate419-570-0—

Xn; R22

R52-53

Xn

R: 22-52/53

S: (2-)61

607-674-00-0branched C10-alkyl benzoates421-090-1131298-44-7Xn; R20

Xn

R: 20

S: (2-)23

607-675-00-6

mixture of: cis-9-octadecenedioic acid;

cis-9-cis-12-octadecadienedioic acid;

hexadecanedioic acid;

octadecanedioic acid

422-260-8—

Xi; R41

N; R50-53

Xi; N

R: 41-50/53

S: (2-)26-39-60-61

607-676-00-1

mixture of: 2-methylnonanedioic acid;

2,4-dimethyl-4-methoxycarbonylundecanedioic acid;

2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid;

8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid

423-670-1—

Xi; R41

R43

Xi

R: 41-43

S: (2-)24-26-37/39

607-677-00-72,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-L-valinate424-660-8—

Xn; R48/22

Xi; R41

R43

Xn

R: 41-43-48/22

S: (2-)22-26-36/37/39

607-678-00-2

mixture of: ethyl (2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate;

ethyl (2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate

427-090-8—

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)23-25-36/37-61

607-679-00-8

mixture of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate);

3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate);

3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate)

431-440-5—

Xi; R41

N; R51-53

Xi; N

R: 41-51/53

S: (2-)22-26-39-61

607-680-00-3 tert-butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate432-810-9—R53

R: 53

S: 61

607-681-00-9

mixture of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid;

9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid;

dihexadecyl 9-nonyl-10-octylnonadecandioate;

1-octadecyl,19-hexadecyl 9-nonyl-10-octylnonadecandioate;

dioctadecyl 9-nonyl-10-octylnonadecandioate

432-910-2—R53

R: 53

S: 61

607-682-00-4complex mixture of Chinese gum rosin post reacted with acrylic acid434-230-1144413-22-9R53

R: 53

S: 61

607-683-00-X

mixture of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;

methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80)

435-450-0—

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

607-684-00-5alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts435-660-2243662-67-1

Xi; R38

R43

Xi

R: 38-43

S: (2-)24-37

607-685-00-0ammonium 2-cocoyloxyethanesulfonate441-050-7—Xi; R38-41

Xi

R: 38-41

S: (2-)26-37/39

607-686-00-66,6′-bis(diazo-5,5′,6,6′-tetrahydro-5,5′-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)441-550-5—

E; R2

F; R11

Carc. Cat. 3; R40

E; Xn

R: 2-11-40

S: (2-)7-22-36/37

607-687-00-1

mixture of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);

2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);

2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);

2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);

2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);

2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);

2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);

2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);

2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);

2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %)

442-800-6—

Xi; R38

N; R51-53

Xi; N

R: 38-51/53

S: (2-)37-61

607-688-00-7(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride444-320-2—Xn; R22

Xn

R: 22

S: (2-)

607-689-00-2

mixture of: methyl 1,4-dimethylcyclohexanecarboxylate (‘para-isomer’ including cis- and trans- isomers);

methyl 1,3-dimethylcyclohexanecarboxylate (‘meta-isomer’ including cis- and trans-isomers)

444-920-4—R52-53

R: 52/53

S: 61

607-690-00-8dimethyl[2S,2S′]-6,6,6′6′-tetramethoxy-2,2′-[N,N′-bis(trifluoracetyl)-S,S′-bi(L-homocysteinyl) diimino]dihexanoate432-860-1255387-46-3R43

Xi

R: 43

S: (2-)24-37

607-691-00-3magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear448-690-6—R53

R: 53

S: 61

607-692-00-9zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear446-470-4—R53

R: 53

S: 61

607-693-00-4hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate443-860-6302776-68-7R53

R: 53

S: 61

607-694-00-Xethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate443-870-0163520-33-0

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)22-36/37-60-61

608-042-00-7(S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide421-810-4194602-27-2

Xn; R22

Xi; R41

R43

N; R51-53

Xn; N

R: 22-41-43-51/53

S: (2-)24-26-37/39-61

608-059-00-X5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile421-240-6120068-79-3N; R51-53

N

R: 51/53

S: 22-61

608-060-00-55-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile421-300-1138564-59-7N; R50-53

N

R: 50/53

S: 22-60-61

608-062-00-62-fluoro-4-hydroxybenzonitrile422-810-782380-18-5

Xn; R22

Xi; R41

N; R51-53

Xn; N

R: 22-41-51/53

S: (2-)22-26-39-61

608-063-00-1(S)-α-hydroxy-3-phenoxy-benzeneacetonitrile441-070-661826-76-4

T; R25

Xi; R41

R43

N; R50-53

T; N

R: 25-41-43-50/53

S: (1/2-)9-26-36/37/39-45-60-61

608-064-00-7cyanomethyltrimethylammoniummethylsulfate433-720-2—R52-53

R: 52/53

S: 61

609-069-00-7

musk ketone;

3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone;

4′-tert-butyl-2′,6′-dimethyl-3′,5′-dinitroacetophenone

201-328-981-14-1

Carc. Cat. 3; R40

N; R50-53

Xn; N

R: 40-50/53

S: (2-)36/37-46-60-61

611-154-00-9trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate403-670-692408-46-3R52-53

R: 52/53

S: 61

611-155-00-44,4′-oxybis(benzenesulfonylazide)431-850-47456-68-0

E; R3

F; R11

Xn; R48/22

N; R50-53

E; Xn; N

R: 3-11-48/22-50/53

S: (2-)14-22-33-35-36-60-61

611-156-00-Xtriammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate432-270-4221354-37-6

Repr. Cat. 3; R62

Xn; R48/22

N; R51-53

Xn; N

R: 48/22-62-51/53

S: (2-)36/37-61

611-157-00-5

benzenesulfonic acid, 3,3′-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt;

potassium sodium 3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate

432-590-4243869-48-9

Xi; R36

R52-53

Xi

R: 36-52/53

S: (2-)26-61

611-158-00-0reaction mixture of: 2,3,4,2′,3′,4′-hexahydroxy-5,5′-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride421-520-8—

F; R11

R53

F

R: 11-53

S: (2-)3-12-16-33-61

611-159-00-6disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate421-880-6—

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)26-39-61

611-160-00-1

mixture of: 1,1,1-tris(phenyl-4′-(3″-diazo-3″,4″-dihydro-4″-oxo-naphthalene-1″-sulfonato)ethane;

1,1,1-tris(phenyl-4′-(6″-diazo-5″,6″-dihydro-5″-oxo-naphthalene-1″-sulfonato)ethane;

reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1);

reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2)

422-760-6—

F; R11

R53

F

R: 11-53

S: (2-)3-12-33-61

611-161-00-7trisodium [1,2′-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4′-nitrobenzene)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1′-enyl)azo)-5-sulfamoylbenzene)diolato-O,O,N]chromate(III)423-100-1—Xi; R41

Xi

R: 41

S: (2-)26-39

611-162-00-22,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate)429-600-4—

Xn; R22

Xi; R41

N; R51-53

Xn; N

R: 22-41-51/53

S: (2-)22-26-39-61

611-163-00-82,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate429-610-9—

Xn; R22

Xi; R41

N; R51-53

Xn; N

R: 22-41-51/53

S: (2-)22-26-39-61

611-164-00-3

mixture of: 2,2′-dimethyl-2,2′-azobutanenitrile;

2-methylpentanenitrile-2-azo-2′-(2′-methylpropanenitrile);

2,2′-dimethyl-2,2′-azoheptanenitrile;

2-methylheptanenitrile-2-azo-2′-(2′-methylpropanenitrile);

2-methylheptanenitrile-2-azo-2′-(2′-methylbutanenitrile)

429-710-2—

R10

R32

R44

Xn; R22

N; R51-53

Xn; N

R: 10-22-32-44-51/53

S: (2-)12-15-16-47-51-61

611-165-00-9

mixture of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate;

tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate

431-830-5—R52-53

R: 52/53

S: 61

611-166-00-4

mixture of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;

tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

tetrasodium 4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate

432-100-9—

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)26-39-61

611-167-00-Xsodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4′-(4,8-disulfonato-2-naphthylazo)-5′-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cuprate(II)435-240-9—R52-53

R: 52/53

S: 61

611-168-00-5

mixture of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid;

3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid

435-440-6—Xi; R41

Xi

R: 41

S: (2-)22-26-39

611-169-00-0sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate435-800-2—R52-53

R: 52/53

S: 61

611-170-00-6

mixture of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N 2)-1-phenylmethyl)azo-κ-N 1)-4-sulfonatobenzoate(5-)-κ-O)cuprate(II);

disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ-O-phenylazo-κ-N 2)-1-phenylmethyl)azo-κ-N 1)-4-sulfonatobenzoate-κ-O-(5-))cuprate(II)

435-880-9—R52-53

R: 52/53

S: 22-61

611-171-00-1

mixture of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate;

trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate

436-890-6—

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)22-26-39-61

611-172-00-7

mixture of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate;

diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate

438-310-7—

E; R2

Repr. Cat. 3; R62

Xn; R22-48/22

R52-53

E; Xn

R: 2-22-48/22-62-52/53

S: (2-)22-35-36/37-61

611-173-00-2

mixture of: 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt;

3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt

440-510-4—

Xi; R41

R43

Xi

R: 41-43

S: (2-)22-26-36/37/39

611-174-00-8

mixture of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt;

3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt

442-290-5457624-86-1Xi; R41

Xi

R: 41

S: (2-)22-26-39

611-175-00-3

mixture of: trisodium 5-{4-chloro-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

trisodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

disodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

tetrasodium 5-{4-chloro-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate

444-050-5—

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)22-26-39-61

611-176-00-92,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate444-250-2—

E; R2

F; R11

N; R51-53

E; N

R: 2-11-51/53

S: (2-)22-61

611-177-00-4

mixture of: pentasodium bis[6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III);

tetrasodium [6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato][6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III);

trisodium bis[6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III)

444-290-0508202-43-5

Xi; R41

R43

R52-53

Xi

R: 41-43-52/53

S: (2-)22-24-26-37/39-61

611-178-00-X

mixture of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;

tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

tetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate

445-280-9—

Xi; R41

R43

R52-53

Xi

R: 41-43-52/53

S: (2-)24-26-37/39-61

611-179-00-5

mixture of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate;

2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate

450-010-8—

Xi; R41

R43

Xi

R: 41-43

S: (2-)22-24-26-37/39

611-180-00-0iron, complexes with diazotised 4-aminobenzenesulfonamide,diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide,diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts417-850-7—N; R51-53

N

R: 51/53

S: 22-61

612-238-00-8(3-chloro-2-hydroxypropyl) trimethylammonium chloride … %B222-048-33327-22-8

Carc. Cat. 3, R40

R52-53

Xn

R: 40-52/53

S: 36/37-61

612-239-00-3

biphenyl-3,3′,4,4′-tetrayltetraamine;

diaminobenzidine

202-110-691-95-2

Carc. Cat. 2; R45

Muta. Cat. 3; R68

T

R: 45-68

S: 53-45

612-240-00-9

pyrimethanil (ISO);

N-(4,6-dimethylpyrimidin-2-yl)aniline

—53112-28-0N; R51-53

N

R: 51/53

S: 61

612-241-00-4

piperazine hydrochloride; [1]

piperazine dihydrochloride; [2]

piperazine phosphate [3]

228-042-7 [1]

205-551-2 [2]

217-775-8 [3]

6094-40-2 [1]

142-64-3 [2]

1951-97-9 [3]

Repr. Cat. 3; R62-63

Xi; R36/38

R42/43

R52-53

Xn

R: 36/38-42/43-62-63-52/53

S: (1/2-)22-36/37-45-63-61

612-242-00-X

cyprodinil (ISO);

4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine

—121552-61-2

R43

N; R50-53

Xi; N

R: 43-50/53

S: (2-)24-37-46-60-61

C ≥ 2,5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

612-243-00-5(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate420-560-379617-97-3

Xi; R41

N; R50-53

Xi; N

R: 41-50/53

S: (2-)26-39-60-61

C ≥ 10 %: Xi, N; R41-50/53

5 % ≤ C < 10 %: Xi, N; R36-50/53

2,5 % ≤ C < 5 %: N; R50/53

0,25 % ≤ C < 2, 5 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

612-244-00-03-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride421-310-687691-88-1

Repr. Cat. 3; R62

Xn; R22

Xi; R36

R43

N; R50-53

Xn; N

R: 22-36-43-62-50/53

S: (2-)22-26-36/37/39-60-61

612-245-00-62-ethylphenylhydrazine hydrochloride421-460-219398-06-2

Carc. Cat. 3; R40

T; R48/25

Xn; R22

Xi; R41

R43

N; R50-53

T; N

R: 22-40-41-43-48/25-50/53

S: (1/2-)22-26-36/37/39-45-60-61

C ≥ 25 %: T, N; R22-40-41-43-48/25-50/53

10 % ≤ C < 25 %: T, N; R40-41-43-48/25-50/53

5 % ≤ C < 10 %: Xn, N; R36-40-43-48/22-50/53

2,5 % ≤ C < 5 %: Xn, N; R40-43-48/22-50/53

1 % ≤ C < 2,5 %: Xn, N; R40-43-48/22-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

612-246-00-1(2-chloroethyl)(3-hydroxypropyl)ammonium chlorideE429-740-640722-80-3

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Xn; R48/22

R43

R52-53

T

R: 45-46-43-48/22-52/53

S: 53-45-61

612-247-00-7 N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N′-hydroxy-4-nitrobenzenecarboximidamide423-530-8152828-23-4

T; R48/25

Xn; R22

R52-53

T

R: 22-48/25-52/53

S: (1/2-)22-36-45-61

612-248-00-2reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich)439-540-0—

Xi; R38

R43

R53

Xi

R: 38-43-53

S: (2-)24-37-61

612-249-00-84-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride425-030-5159939-85-2

Repr. Cat. 3; R62

Xn; R22

C; R34

R43

N; R51-53

C; N

R: 22-34-43-62-51/53

S: (1/2-)22-26-36/37/39-45-61

612-250-00-3chloro-N,N-dimethylformiminium chlorideE425-970-63724-43-4

R14

Repr. Cat. 2; R61

Xn; R22

C; R35

T; C

R: 61-14-22-35

S: 53-45

612-251-00-9 cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride426-020-351229-78-8

F; R11

Repr. Cat. 3; R63

Xn; R22

Xi; R38

R43

N; R51-53

F; Xn; N

R: 11-22-38-43-63-51/53

S: (2-)7-22-33-36/37-61

612-252-00-4

imidacloprid (ISO);

1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine

428-040-8138261-41-3

Xn; R22

N; R50-53

Xn; N

R: 22-50/53

S: (2-)22-57-60-61

612-253-00-X

7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;

[containing < 0,5 % formamide (EC No 200-842-0)]

429-400-7199327-61-2R52-53

R: R52/53

S: 61

612-253-01-7

7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;

[containing ≥ 0,5 % formamide (EC No 200-842-0)]

429-400-7199327-61-2

Repr. Cat. 2; R61

R52-53

T

R: 61-52/53

S: 53-45-61

612-254-00-5reaction products of diisopropanolamine with formaldehyde (1:4)432-440-8220444-73-5

Carc. Cat. 3; R40

Xn; R22

C; R34

R43

N; R51-53

C; N

R: 22-34-40-43-51/53

S: (1/2-)13-25-26-36/37/39-45-61

612-255-00-01-(3-methoxypropyl)-4-piperidinamine431-950-8179474-79-4

Xn; R21/22

C; R34

R52-53

C

R: 21/22-34-52/53

S: (1/2-)26-36/37/39-45-61

612-256-00-6benzyl(S)-2-[(2′-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate427-470-3137864-22-3

Xn; R22

R43

Xn

R: 22-43

S: (2-)36/37

612-257-00-1tripropylammonium dihydrogenphosphate433-700-335687-90-2Xn; R22

Xn

R: 22

S: (2-)22

612-259-00-2 N-ethyl-3-trimethoxysilyl-2-methyl-propanamine437-720-3227085-51-0Xi; R41

Xi

R: 41

S: (2-)26-39

612-261-00-33,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline441-190-9121451-05-6

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)24-37-60-61

C ≥ 25 %: Xn, N; R22-43-50/53

2,5 % ≤ C < 25 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

612-265-00-5bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate444-360-0191617-13-7R52-53

R: 52/53

S: 61

612-266-00-03-chloro-4-(3-fluorobenzyloxy)aniline445-590-4202197-26-0

Muta. Cat. 3; R68

Xn; R22-48/22

N; R50-53

Xn; N

R: 22-48/22-68-50/53

S: (2-)22-36/37-60-61

612-267-00-6bis(hydrogenated tallow C16-18-alkyl)hydroxylamine418-370-0—

R43

R53

Xi

R: 43-53

S: (2-)36/37-61

612-269-00-7

mixture of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole;

1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole;

mixture of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline;

N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline

420-720-2—R53

R: 53

S: 22-61

612-270-00-2(S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride433-010-2—

Xn; R22

R43

R52-53

Xn

R: 22-43-52/53

S: (2-)22-36/37-61

612-271-00-8

mixture of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate;

ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate

434-970-5160987-57-5R53

R: 53

S: 61

612-272-00-3ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate435-210-5—N; R51-53

N

R: 51/53

S: 61

612-273-00-9alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride435-650-8—

Xn; R22

C; R35

N; R50-53

C; N

R: 22-35-50/53

S: (1/2-)26-36/37/39-45-60-61

612-274-00-4(R,S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate445-750-3—

Xn; R22

Xi; R41

R43

R52-53

Xn

R: 22-41-43-52/53

S: (2-)22-24-26-37/39-61

612-275-00-Xfatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil447-880-6206565-89-1

Xi; R38-41

R43

N; R50-53

Xi; N

R: 38-41-43-50/53

S: (2-)23-26-36/37/39-60-61

C ≥ 20 %: Xi, N; R38-41-43-50/53

10 % ≤ C < 20 %: Xi, N; R41-43-50/53

5 % ≤ C < 10 %: Xi, N; R36-43-50/53

2,5 % ≤ C < 5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

612-276-00-51-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts451-430-4500717-36-2

Xi; R41

R43

R52-53

Xi

R: 41-43-52/53

S: (2-)22-24-26-36/37/39-61

612-277-00-0

mixture of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium;

4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium

451-440-9586372-44-3Xi; R41

Xi

R: 41

S: (2-)22-26-39

612-278-00-6

ethidium bromide;

3,8-diamino-1-ethyl-6-phenylphenantridinium bromide

214-984-61239-45-8

Muta. Cat. 3; R68

T+; R26

Xn; R22

T+

R: 22-26-68

S: (1/2-)28-36/37-45-63

612-279-00-1(R,S)-2-amino-3,3-dimethylbutane amide447-860-7144177-62-8

Repr. Cat. 3; R62

Xn; R48/22

Xi; R36/38

R43

Xn

R: 36/38-43-48/22-62

S: (2-)22-26-36/37

612-280-00-7

3-amino-9-ethyl carbazole;

9-ethylcarbazol-3-ylamine

H205-057-7132-32-1Carc. Cat. 2; R45

T

R: 45

S: 53-45

613-116-01-4

tolylfluanid (ISO);

dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;

[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

211-986-9731-27-1

Xi; R36/37/38

R43

N; R50

Xi; N

R: 36/37/38-43-50

S: (2-)25-36/37-46-61

C ≥ 20 %: Xi, N; R36/37/38-43-50

2,5 % ≤ C < 20 %: Xi, N; R43-50

1 % ≤ C < 2,5 %: Xi; R43

613-280-00-X

tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one;

dimethyl propyleneurea

230-625-67226-23-5

Repr. Cat. 3; R62

Xn; R22

Xi; R41

Xn

R: 22-41-62

S: 26-36/37/39

613-281-00-5quinolineE202-051-691-22-5

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Xn; R21/22

Xi; R36/38

N; R51-53

T; N

R: 45-21/22-36/38-68-51/53

S: 53-45-61

613-282-00-0

triticonazole (ISO);

(RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol

—131983-72-7N; R51-53

N

R: 51/53

S: 61

613-283-00-6

ketoconazole;

1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone

E265-667-465277-42-1

Repr. Cat. 2; R60

T; R25

Xn; R48/22

N; R50-53

T; N

R: 60-25-48/22-50/53

S: 53-45-60-61

613-284-00-1

metconazole (ISO);

(1RS,5RS;1RS,5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol

—125116-23-6

Repr. Cat. 3; R63

Xn; R22

N; R51-53

Xn; N

R: 22-63-51/53

S: (2-)36/37-46-61

613-285-00-7

1-hydroxybenzotriazole, anhydrous; [1]

1-hydroxybenzotriazole, monohydrated [2]

219-989-7 [1]

219-989-7 [2]

2592-95-2 [1]

123333-53-9 [2]

E; R2

E

R: 2

S: 16-35

613-286-00-2

potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;

[containing < 0,5 % N,N-dimethylformamide (EC No 200-679-5)]

418-260-2183196-57-8R43

Xi

R: 43

S: (2-)24-37

613-286-01-X

potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;

[containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)]

418-260-2183196-57-8

Repr. Cat. 2; R61

R43

T

R: 61-43

S: 53-45

613-287-00-81-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole419-540-7160194-26-3

Xn; R22

R43

N; R51-53

Xn; N

R: 22-43-51/53

S: (2-)24-37-61

613-288-00-31,3-bis(dimethylcarbamoyl)-imidazolium chloride420-930-4135756-61-5

Xn; R22

Xi; R41

R52-53

Xn

R: 22-41-52/53

S: (2-)22-26-37/39-61

613-289-00-93-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole432-020-4142623-48-1N; R50-53

N

R: 50/53

S: 60-61

613-290-00-44-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride432-470-1189012-93-9

Xi; R41

R43

N; R50-53

Xi; N

R: 41-43-50/53

S: (2-)24-26-37/39-60-61

613-291-00-X2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one434-820-9106461-41-0

Xn; R48/22

N; R50-53

Xn; N

R: 48/22-50/53

S: (2-)22-36-60-61

613-292-00-5 N,N′,N″-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine435-010-826157-73-3

Muta. Cat. 3; R68

R52-53

Xn

R: 68-52/53

S: (2-)36/37-61

613-293-00-02-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester448-050-6444065-11-6R53

R: 53

S: 61

613-294-00-62-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester448-260-8379268-96-9R53

R: 53

S: 61

613-295-00-111-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine hydrochloride448-720-8363138-44-7

Xn; R22

Xi; R41

R52-53

Xn

R: 22-41-52/53

S: (2-)22-26-39-61

613-296-00-7pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate418-270-7—

R43

R52-53

Xi

R: 43-52/53

S: (2-)24-37-47-61

613-297-00-25-(2-bromophenyl)-2-tert-butyl-2H-tetrazole420-820-6—

R10

Xn; R22

N; R51-53

Xn; N

R: 10-22-51/53

S: (2-)16-61

613-298-00-8bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate421-560-6—

Xn; R48/22

Xi; R41

N; R51-53

Xn; N

R: 41-48/22-51/53

S: (2-)22-26-36/39-61

613-299-00-3

main component 1 (isomer 1): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;

main component 1 (isomer 2): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;

main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;

main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt

422-610-1—Xi; R41

Xi

R: 41

S: (2-)22-26-39

613-300-00-71-imidazol-1-yl-octadecan-2-ol434-120-3—

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

613-301-00-2dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole-4,5-dicarboxylate443-910-7—R53

R: 53

S: 61

613-302-00-8disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate432-980-4243858-60-8Xi; R41

Xi

R: 41

S: (2-)22-26-39

613-303-00-32-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine429-800-195737-68-1N; R50-53

N

R: 50/53

S: 60-61

613-304-00-95,6-dihydroxy-2,3-dihydro-1H-indolium bromide421-170-6138937-28-7

Xn; R22

Xi; R41

Xn

R: 22-41

S: (2-)22-26-39

613-305-00-42-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole448-630-93147-77-1R53

R: 53

S: 61

613-306-00-X(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate433-520-582911-69-1

Xn; R22

R43

N; R51-53

Xn; N

R: 22-43-51/53

S: (2-)24-37-61

613-307-00-5

clothianidin (ISO);

3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine

—210880-92-5

Xn; R22

N; R50-53

Xn; N

R: 22-50/53

S: (2-)46-60-61

C ≥ 25 %: Xn, N; R22-50/53

2,5 % ≤ C < 25 %: N; R50/53

0,25 % ≤ C < 2,5 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

613-308-00-02-amino-5-methylthiazole423-800-57305-71-7

Xn; R22-48/22

N; R50-53

Xn; N

R: 22-48/22-50/53

S: (2-)22-36-60-61

613-309-00-61-methyl-3-phenyl-1-piperazine431-180-25271-27-2

Xn; R21/22

Xi; R38-41

R52-53

Xn

R: 21/22-38-41-52/53

S: (2-)26-36/37/39-61

613-310-00-1(-)(3S,4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride432-360-3105813-13-6

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)22-24-37-60-61

613-311-00-7methyl-5-nitrophenyl-guanidine435-500-1152460-07-6

Xn; R22

Xi; R36

R43

R52-53

Xn

R: 22-36-43-52/53

S: (2-)22-24-26-37-61

613-312-00-22-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride420-200-5—

Xn; R22

Xi; R41

R43

R52-53

Xn

R: 22-41-43-52/53

S: (2-)22-26-36/37/39-61

613-313-00-82-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione442-780-9173838-67-0R52-53

R: 52/53

S: 61

613-314-00-3

4-decyloxazolidin-2-one;

4-decyl-1,3-oxazolidin-2-one

443-770-77693-82-5N; R50-53

N

R: 50/53

S: 22-24-60-61

613-315-00-9tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate430-390-1—

Xn; R20

R52-53

Xn

R: 20-52/53

S: (2-)25-61

613-316-00-4

trimethylopropane tri(3-aziridinylpropanoate);

(TAZ)

H257-765-052234-82-9

Muta. Cat. 3; R68

Xi; R41

R43

Xn

R: 41-43-68

S: 26-36/37/39-42

615-044-00-14-chlorophenylisocyanate203-176-9104-12-1

T+; R26

Xn; R22

Xi; R37/38-41

R42

N; R50-53

T+; N

R: 22-26-37/38-41-42-50/53

S: (1/2-)26-28-36/37/39-45-63-60-61

615-045-00-74,4′-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)420-530-1—

R42/43

R53

Xn

R: 42/43-53

S: (2-)23-24-37-45-61

616-126-00-X1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide423-960-6139756-01-7

Xn; R22-48/22

R52-53

Xn

R: 22-48/22-52/53

S: (2-)22-36/37-61

616-164-00-7

dimoxystrobin (ISO);

(E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide

—149961-52-4

Carc. Cat. 3; R40

Repr. Cat. 3; R63

Xn; R20

N; R50-53

Xn; N

R: 20-40-63-50/53

S: (2-)36/37-46-60-61

C ≥ 25 %: Xn, N; R20-40-63-50/53

5 % ≤ C < 25 %: Xn, N; R40-63-50/53

2,5 % ≤ C < 5 %: Xn, N; R40-50/53

1 % ≤ C < 2,5 %: Xn, N; R40-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52-53

616-165-00-2

beflubutamid (ISO);

(RS)-N-benzyl-2-(α,α,α,4-tetrafluoro-m-tolyoxy)butyramide

—113614-08-7N; R50-53

N

R: 50/53

S: 60-61

C ≥ 0,25 %: N; R50/53

0,025 % ≤ C < 0,25 %: N; R51/53

0,0025 % ≤ C < 0,025 %: R52/53

616-166-00-8

cyazofamid (ISO);

4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide

—120116-88-3N; R50-53

N

R: 50/53

S: 60-61

C ≥ 2,5 %: N; R50/53

0,25 % ≤ C < 2,5 %: N; R51-53

0,025 % ≤ C < 0,25 %: R52/53

616-167-00-3 N,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide418-290-6168612-06-4

Xi; R36

R43

Xi

R: 36-43

S: (2-)24-26-37

616-168-00-91-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium418-440-0136997-71-2R43

Xi

R: 43

S: (2-)22-24-37

616-169-00-44-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one420-220-492771-56-7

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

616-170-00-X(2R)-2-amino-2-phenylacetamide420-370-06485-67-2

Xi; R36

R43

Xi

R: 36-43

S: (2-)22-26-36/37

616-171-00-52-(para-chlorophenyl)glycineamide420-830-0102333-75-5

Xi; R41

R43

Xi

R: 41-43

S: (2-)24-26-37/39

616-172-00-0

N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide;

(4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl

423-840-314691-89-5Xn; R22

Xn

R: 22

S: (2-)22

616-174-00-12-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride424-560-4151257-01-1

Xn; R22

Xi; R36

Xn

R: 22-36

S: (2-)22-26

616-175-00-72-(2-hexyldecyloxy)benzamide431-230-3202483-62-3R53

R: 53

S: 61

616-176-00-23-N,N-bis(methoxyethyl)aminoacetanilide432-530-724294-01-7

Xn; R22

R52-53

Xn

R: 22-52/53

S: (2-)22-24-61

616-177-00-8

(3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide;

N-[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl}amino)-4-chlorophenyl]tetradecanamide

432-970-1217324-98-6R53

R: 53

S: 61

616-178-00-3 N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide434-500-952583-35-4R53

R: 53

S: 22-61

616-179-00-92-chloro-N-(4-methylphenyl)acetamide435-170-916634-82-5

Xi; R41

R43

N; R50-53

Xi; N

R: 41-43-50/53

S: (2-)22-26-36/37/39-60-61

616-180-00-4 N,N-(dimethylamino)thioacetamide hydrochloride435-470-127366-72-9

Repr. Cat. 2; R61

N; R50-53

T; N

R: 61-50/53

S: 53-45-60-61

616-181-00-X4′-methyldodecane-1-sulfonanilide435-490-917417-32-2N; R50-53

N

R: 50/53

S: 60-61

616-182-00-5 N′-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide435-860-1214417-91-1

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

616-183-00-0 N-dodecyl-4-methoxybenzamide442-340-61854-15-5R53

R: 53

S: 61

616-184-00-63-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide442-560-2105043-55-8R53

R: 53

S: 61

616-186-00-7 N,N′-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide)443-010-453641-10-4R52-53

R: 52/53

S: 61

616-188-00-82-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide443-980-9221215-20-9

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

616-189-00-3 N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide444-780-4452962-97-9R53

R: 53

S: 61

616-190-00-9 N-decyl-4-nitrobenzamide445-880-064026-19-3R53

R: 53

S: 61

616-191-00-42-ethyl-N-methyl-N-(3-methylphenyl)butanamide446-190-2406488-30-0

Xn; R22

Xi; R36/38

R43

N; R51-53

Xn; N

R: 22-36/38-43-51/53

S: (2-)24-26-37-61

616-192-00-X2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5′-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2′-[(2-ethylhexyl)thio]acetanilide448-060-0727678-39-9R53

R: 53

S: 61

616-193-00-5 N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide449-940-7368450-39-9R53

R: 53

S: 61

616-194-00-02,2-diethoxy-N,N-dimethylacetamide449-950-134640-92-1Xi; R36

Xi

R: 36

S: (2-)26

616-196-00-1disodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide419-990-4—N; R50-53

N

R: 50/53

S: 60-61

616-197-00-7

mixture of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate;

N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide

422-500-1—Xn; R48/22

Xn

R: 48/22

S: (2-)22-36

616-198-00-21,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene423-300-7—

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

616-200-00-1

mixture of: N,N′-ethane-1,2-diylbis(hexanamide);

12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide;

N,N′-ethane-1,2-diylbis(12-hydroxyoctadecanamide)

432-430-3—

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

616-201-00-712-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine432-840-2220926-97-6

Xn; R20

R53

Xn

R: 20-53

S: (2-)22-61

616-202-00-2

mixture of: 2,2′-[(3,3′-dichloro[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide;

2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide;

2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide

434-330-5—

Carc. Cat. 3; R40

R43

R53

Xn

R: 40-43-53

S: (2-)36/37-61

616-203-00-8

mixture of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide;

N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl]acetamide

442-280-0—R53

R: 53

S: 61

616-204-00-3 N,N″-(methylenedi-4,1-phenylene)bis[N′-octylurea]451-060-3122886-55-9R53

R: 53

S: 61

617-022-00-7

mixture of: 1,2-dimethylpropylidene dihydroperoxide;

dimethyl 1,2-benzenedicarboxylate

442-480-8—

O; R7

Xn; R22

C; R34

R43

N; R51-53

O; C; N

R: 7-22-34-43-51/53

S: (1/2-)3/7-14-26-36/37/39-45-50-61

647-017-00-5laccase420-150-480498-15-3R42

Xn

R: 42

S: (2-)23-45

ANNEX 1CU.K.

The entries in Annex I with the following Index numbers are deleted:

024-004-01-4, 603-037-01-3, 603-155-00-8, and 611-084-00-9.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources

The data on this page is available in the alternative data formats listed: